syndrome	score	normalized_score
DRAVET SYNDROME	2.7202119	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	55.905234809097045
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	1.34778266	49.546973160436515
MYOCLONIC-ASTASTIC EPILEPSY	1.2207122540000002	44.8756309756604
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	43.88239019173469
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15211626	42.353915884273576
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	1.0909091	40.10382794075712
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	1.0664150790000002	39.203382611479654
HYPERLIPOPROTEINEMIA, TYPE I	1.0232558	37.616768017226896
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0232558	37.616768017226896
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.00270409	36.86124930193858
EHLERS-DANLOS SYNDROME, TYPE I	1.00163132	36.82181230072554
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	36.78174553239768
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	36.78174553239768
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	36.761841972678674
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.0	36.761841972678674
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.0	36.761841972678674
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	34.35176355194976
LAFORA DISEASE	0.82300606	30.255218720276904
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.329304051643923
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.7659786500000001	28.158786085745753
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999998	27.519141578639513
EARLY MYOCLONIC ENCEPHALOPATHY	0.7307892039999999	26.865157232787634
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.705447414	25.93354635350283
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.7029457100000001	25.841579106392416
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.6271692	23.055895020531306
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.6271692	23.055895020531306
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.6198357	22.786302052424666
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.610695934	22.450307419065407
BILATERAL POLYMICROGYRIA	0.606829964	22.30818724085429
ROLANDIC EPILEPSY	0.5906213	21.712326896298045
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5564516399999999	20.45618725511788
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	19.66060438159248
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.374483289334925
MEDULLOBLASTOMA	0.519029304	19.0804732528374
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.518324164	19.054551007588785
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.639807067971432
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.380920986339337
INHALATIONAL ANTHRAX	0.5	18.380920986339337
PAROXYSMAL HEMICRANIA	0.5	18.380920986339337
CREST SYNDROME	0.5	18.380920986339337
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.380920986339337
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.48410971	17.796764656459303
SPINOCEREBELLAR ATAXIA TYPE 10	0.44863226	16.492548245965693
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43961311999999997	16.160988046556227
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.434614804	15.977240743634717
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.42920530399999995	15.77837755948351
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.42691399999999996	15.694145003924142
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.41931104999999996	15.414646557497965
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.398794304	14.66041318325238
GLOMUVENOUS MALFORMATION	0.392857	14.442146951860627
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.385930204	14.187505171931644
PLACENTAL INSUFFICIENCY	0.3768113	13.852277464119616
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.36507529	13.420840119109839
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.40189380099396
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.143007719361863
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.143007719361863
CENTRALOPATHIC EPILEPSY	0.3547009	13.039458433366901
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34912821	12.834596084224176
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.348076944	12.795949609660925
COG4-CDG	0.344567104	12.66692142623154
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.512821151910996
SPINOCEREBELLAR ATAXIA TYPE 42	0.33846121	12.442457515901612
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33496432	12.31390539832577
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.2539350702789
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.2539350702789
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.333333	12.2539350702789
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.2539350702789
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.31587301	11.612073677054351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.31332961400000003	11.51857375522841
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.304116984	11.179900507015649
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.29943673000000004	11.007845749075654
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.29653465	10.90115994272358
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.2630543	9.670360606833608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.397427972431121
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25512821	9.37898293879238
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.254187719	9.344408757273651
PALLISTER-HALL SYNDROME	0.250545554	9.210516063105231
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	9.210516063105231
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.250168973	9.196672251893318
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.190460493169669
HYPERPARATHYROIDISM 2	0.25	9.190460493169669
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	9.190460493169669
HYPEREKPLEXIA 1; HKPX1	0.25	9.190460493169669
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.190460493169669
SEVERE HEMOPHILIA A	0.25	9.190460493169669
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	9.190460493169669
DYSTONIA 6, TORSION	0.25	9.190460493169669
CONGENITAL FACTOR II DEFICIENCY	0.25	9.190460493169669
HEMOPHILIA B	0.25	9.190460493169669
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	9.190460493169669
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	9.190460493169669
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.24651401	9.062309079671332
TRICHOTHIODYSTROPHY	0.24434208400000001	8.98246507928298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	8.934787543573353
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.549749745598863
UNILATERAL POLYMICROGYRIA	0.23245136	8.545340162654242
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.227471804	8.362282511888138
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.305571709321617
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.22536641400000001	8.28488449741728
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.22463191000000005	8.257882777440981
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.22332433	8.209813728114343
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.222851819	8.192443353401991
CONGENITAL MYASTHENIC SYNDROME	0.222851819	8.192443353401991
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.140424648535653
CLEFT VELUM	0.2208333	8.118238876905142
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.214156114	7.872773220350959
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.20952369999999998	7.702477148930935
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.20952369999999998	7.702477148930935
AUTOIMMUNE HYPOPARATHYROIDISM	0.20952369999999998	7.702477148930935
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.20952369999999998	7.702477148930935
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.20952369999999998	7.702477148930935
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.20657895	7.59422271478189
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.206135503	7.577920786244631
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.543099859242583
ADNP SYNDROME	0.204591729	7.521168810415101
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.202661814	7.450221580164398
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20216920000000002	7.432112182142871
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20216920000000002	7.432112182142871
ROMANO-WARD SYNDROME	0.200541419	7.372271954254741
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.352368394535736
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.352368394535736
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.352368394535736
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.2	7.352368394535736
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.352368394535736
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.186788954	6.866706009189946
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.66440044615642
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.66440044615642
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.17511509999999997	6.437553633229823
WRINKLY SKIN SYNDROME	0.16843297399999999	6.1919063731762956
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.163416204	6.007480667223021
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.1611447	5.923975996134714
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15970406399999998	5.871015563162561
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.863723337141493
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.863723337141493
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.157487054	5.789514191890713
DE BARSY SYNDROME	0.15693867399999997	5.769354732989735
EHLERS-DANLOS SYNDROME, TYPE VI	0.15603914	5.736286206232684
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15281849	5.6178891798833765
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.15220579	5.595365199306716
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.45741675492266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14829852	5.4517267570221275
FREE SIALIC ACID STORAGE DISEASE	0.146648063	5.3910529176054265
PHACE SYNDROME	0.14517096299999996	5.336752000827581
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14517096299999996	5.336752000827581
COMBINED SAPOSIN DEFICIENCY	0.1450262	5.331430246298092
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.143881114	5.289334775720966
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14339841899999997	5.271590018409962
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.14339841899999997	5.271590018409962
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.251686458690957
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	5.251686458690957
GANGLIONEUROMA	0.14285699999999998	5.251686458690957
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	5.251686458690957
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	5.251686458690957
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.251686458690957
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	5.251686458690957
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	5.251686458690957
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.251686458690957
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.251686458690957
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	5.251686458690957
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	5.251686458690957
SCHINZEL-GIEDION SYNDROME	0.14162570000000002	5.206421602669999
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.057205433150263
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.1365903	5.021311023600772
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.870161034145907
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.1316284	4.838902439916538
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.128791063	4.734596705499304
NIEMANN-PICK DISEASE, TYPE C2	0.128791063	4.734596705499304
LATHOSTEROLOSIS	0.128399729	4.720210546832767
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12752318	4.687986991013458
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.127018519	4.669434723081683
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.12649583	4.650219712662826
NON-DISTAL MONOSOMY 20Q	0.12376703900000001	4.549904329144359
SPINOCEREBELLAR ATAXIA 13	0.12121730000000001	4.456171226954783
SPINOCEREBELLAR ATAXIA TYPE 37	0.1211226	4.45268988051997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12091581399999998	4.445088046265807
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.12036106	4.424694267384097
CEREBELLAR ATAXIA, CAYMAN TYPE	0.119758264	4.402534376090333
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.11974119	4.401906704400492
PAPILLARY TUMOR OF THE PINEAL REGION	0.1185898	4.359579487171569
PINEOCYTOMA	0.1185898	4.359579487171569
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.343531105058396
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.112707729	4.143343722597494
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.11195644999999999	4.115725322722101
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.1114059	4.095486090624044
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.1070381	3.9349177172557774
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.924652487550695
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.10633090400000002	3.9089198896600674
AICARDI SYNDROME; AIC	0.10491369	3.8568204925505993
EPISODIC ATAXIA, TYPE 1; EA1	0.1045184	3.842288904037219
NOONAN SYNDROME 7; NS7	0.103573389	3.8075485589927758
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.1029573	3.7848999925336706
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.1028139	3.779628344394788
8Q24.3 MICRODELETION SYNDROME	0.10236869300000001	3.763261715015658
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.10208479399999999	3.752825064841456
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10179004400000001	3.7419895119200097
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.1015267	3.732308501407556
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.10108697300000001	3.7161433269224364
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.10054555400000001	3.6962397672034304
THYROCEREBRORENAL SYNDROME	0.100541419	3.696087756986873
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.10025636	3.6856084630759836
PSEUDOAMINOPTERIN SYNDROME	0.09993327400000002	3.673731226600399
17Q23.1Q23.2 MICRODELETION SYNDROME	0.09951041	3.6581859670564634
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.09912173399999999	3.643897521365891
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.09902601300000001	3.640378641090425
CONGENITAL ANALBUMINEMIA	0.0989922	3.639135612927802
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.637698371954038
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.617139311830818
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.617139311830818
PRADER-WILLI SYNDROME	0.09829781900000001	3.6136088883369712
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.6071399437668807
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.6071399437668807
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.6071399437668807
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.6071399437668807
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.6071399437668807
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.09775640000000001	3.593705328617966
ALSTROM SYNDROME; ALMS	0.096727054	3.555864673630757
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.09601120399999999	3.5295487090546143
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.095328954	3.5044679423687546
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.09515970300000001	3.4982459638530377
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.094682104	3.4806885448887277
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.09450785	3.4742826468776205
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.09446700000000001	3.4727809256330366
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.094365144	3.4690365114570674
MARINESCO-SJÖGREN SYNDROME	0.094158744	3.4614488672739063
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0930783	3.4217297556855777
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.092920609	3.415932744063064
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.09290085000000001	3.4152063668275257
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.09213609	3.3870923805605004
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.09184856	3.3765222481380954
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.09145051900000001	3.3618895277974485
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.09145051900000001	3.3618895277974485
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.091414554	3.3605673881509013
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.09137276000000001	3.3590309637274953
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.091167254	3.351476184631058
POSTAXIAL TETRAMELIC OLIGODACTYLY	0.0909091	3.3419859680784434
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0909091	3.3419859680784434
CORNEODERMATOOSSEOUS SYNDROME	0.0909091	3.3419859680784434
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.0909091	3.3419859680784434
RARE CIRCULATORY SYSTEM DISEASE	0.0909091	3.3419859680784434
KUFOR-RAKEB SYNDROME	0.0909091	3.3419859680784434
TRISOMY 18P	0.0909091	3.3419859680784434
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0909091	3.3419859680784434
SPINOCEREBELLAR ATAXIA TYPE 12	0.0909091	3.3419859680784434
SAGLIKER SYNDROME	0.0909091	3.3419859680784434
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.09025541000000001	3.317955119599323
AICARDI SYNDROME	0.09017920999999998	3.315153867241004
SLC35A2-CDG	0.089845904	3.3029009247404586
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.089369319	3.28538078228391
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08915431	3.277476655403206
AMISH INFANTILE EPILEPSY SYNDROME	0.08873365	3.262012418958979
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.08825747	3.244507165048429
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.08662845999999999	3.1846217568565156
WILLIAMS SYNDROME	0.08443729000000001	3.104070311581242
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.08428160000000001	3.0983468604045155
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.08396535000000001	3.0867209278806556
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.083312354	3.0627155921198645
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.08226293900000001	3.024137163726106
DERMATOMYOSITIS	0.08219867	3.0217745169043635
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.081429344	2.9934926760668903
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.081110819	2.981783110352543
DDOST-CDG	0.08103594900000001	2.9790307512440486
TRISOMY 8P	0.08103594900000001	2.9790307512440486
BECKWITH-WIEDEMANN SYNDROME	0.08097168	2.9766681044223064
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.08035600999999999	2.954034941174987
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.080224004	2.949182157463542
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.07978141000000001	2.9329115867774864
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.079545804	2.924250276237671
HSD10 DISEASE	0.07948717300000001	2.922094892680972
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.07937742900000001	2.918060501095522
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.07920906900000001	2.9118712773810014
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.07896718300000001	2.9029791024735982
ETHYLMALONIC ENCEPHALOPATHY	0.078941619	2.9020393227454084
NEUROFIBROMATOSIS TYPE 1	0.078941619	2.9020393227454084
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.078421629	2.882923532538036
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.07837885	2.881350897700286
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.07788021	2.8630199728190298
PEDIATRIC-ONSET GRAVES DISEASE	0.07746865400000001	2.847890416184122
N SYNDROME	0.07746865400000001	2.847890416184122
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.847890416184122
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.847890416184122
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.07692310000000001	2.8278348462485594
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.8278348462485594
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	2.8278348462485594
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.8278348462485594
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.8278348462485594
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.8278348462485594
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.8278348462485594
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.8278348462485594
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.8278348462485594
DERMOODONTODYSPLASIA	0.07692310000000001	2.8278348462485594
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.07647713	2.8114401675840037
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8052630752773347
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.076018599	2.7945837234224293
GRISCELLI SYNDROME	0.075219663	2.7652133644441452
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.07501014	2.757510913028504
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.074483139	2.73813738554706
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.7250726312902316
NIEMANN-PICK DISEASE TYPE B	0.0741225	2.724879631619875
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0735978	2.705590693136811
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.07305992000000001	2.6858172335765467
KENNEDY DISEASE	0.07265559	2.6709533180117333
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07265559	2.6709533180117333
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.6658060351842447
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.072369839	2.6604485849061983
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0723447	2.659524428960847
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.072287404	2.6574181224631803
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.07197415400000001	2.645902475465239
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.645902475465239
3MC SYNDROME 2	0.07197415400000001	2.645902475465239
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.645902475465239
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.07197415400000001	2.645902475465239
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.07197415400000001	2.645902475465239
GM2 GANGLIOSIDOSIS, AB VARIANT	0.07197001900000001	2.6457504652486823
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.071920273	2.643921710657909
3MC SYNDROME 3	0.07142860000000001	2.6258469055296763
3MC SYNDROME 1	0.07142860000000001	2.6258469055296763
STIFF SKIN SYNDROME	0.07142860000000001	2.6258469055296763
HYPOALPHALIPOPROTEINEMIA	0.07142860000000001	2.6258469055296763
3MC SYNDROME	0.07142860000000001	2.6258469055296763
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07142860000000001	2.6258469055296763
ADULT-ONSET STILL DISEASE	0.07142860000000001	2.6258469055296763
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.6258469055296763
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07142860000000001	2.6258469055296763
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.07142860000000001	2.6258469055296763
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.07142860000000001	2.6258469055296763
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.6258469055296763
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	2.6258469055296763
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.07141057399999999	2.6251842365662763
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.07123096	2.6185812950821954
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.071001303	2.610138680740276
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.06878306000000001	2.528591982117276
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5253069439185967
PONTINE TEGMENTAL CAP DYSPLASIA	0.068658623	2.5240174487877214
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.0683405	2.512322661333847
SPINOCEREBELLAR ATAXIA TYPE 26	0.0683405	2.512322661333847
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06789368999999999	2.4958971027220342
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.06789368999999999	2.4958971027220342
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.06773266400000001	2.489977490356542
CHRISTIANSON SYNDROME	0.0677057	2.48898624404959
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067378873	2.4769714815231865
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.47084626017554
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.4706942499589832
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.066876204	2.458492443180621
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.066856414	2.4577649263279824
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.450790690239977
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.450790690239977
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.450790690239977
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.450790690239977
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.450790690239977
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.450790690239977
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.4370123518686175
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.06565660000000001	2.4136575536633753
SPINOCEREBELLAR ATAXIA 5; SCA5	0.06482011400000001	2.382906787519017
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.382711435090774
WILLIAMS-BEUREN SYNDROME; WBS	0.06428031999999999	2.363062965793216
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.063748	2.34349390207432
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0627413	2.3064857557604244
FABRY DISEASE	0.062258719000000004	2.2887451892994073
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.06216575	2.285327477613049
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.062061939999999996	2.2815112307978653
SPINOCEREBELLAR ATAXIA 1	0.061972440000000004	2.278221045941311
WHITE-SUTTON SYNDROME; WHSUS	0.061841784000000004	2.2734178907165288
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.061511063000000005	2.2612599775774824
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.061387573	2.256720257712276
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06109522999999999	2.245973190544457
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.2321680160284574
GIANT CELL ARTERITIS	0.0603006	2.216761128057708
SPINOCEREBELLAR ATAXIA TYPE 34	0.060291899999999995	2.216441300032545
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.060277554000000004	2.2159139146476057
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.20703026848754
DYSTONIA-APHONIA SYNDROME	0.059910473	2.202419340934432
LYSINURIC PROTEIN INTOLERANCE	0.059889200000000004	2.2016373062701478
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.059871714	2.2009944887014137
MACHADO-JOSEPH DISEASE TYPE 2	0.0597517	2.1965825529989043
MACHADO-JOSEPH DISEASE TYPE 1	0.0597517	2.1965825529989043
MACHADO-JOSEPH DISEASE TYPE 3	0.0597517	2.1965825529989043
15Q OVERGROWTH SYNDROME	0.059708969	2.19501168272957
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.191159446071095
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.191159446071095
EMANUEL SYNDROME	0.059459203	2.185829824507422
7Q11.23 MICRODUPLICATION SYNDROME	0.059259469	2.178487234762851
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.059210599999999995	2.1766907203074877
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.173618533173831
GITELMAN SYNDROME	0.059127030000000004	2.173618533173831
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.058852919	2.163541707908858
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0588235	2.162460211279864
MYASTHENIA GRAVIS; MG	0.0588235	2.162460211279864
CLEFT LIP AND ALVEOLUS	0.0588235	2.162460211279864
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.0588235	2.162460211279864
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0588235	2.162460211279864
OROMANDIBULAR DYSTONIA	0.0588235	2.162460211279864
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0588235	2.162460211279864
CITRULLINEMIA TYPE II	0.058806973	2.1618526483175815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.058323464000000005	2.144077966867214
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.05812102399999999	2.1366358995782644
ANGELMAN SYNDROME	0.057780872999999996	2.124131322269416
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.124022396931651
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.05772	2.1218935186630135
DYSBETALIPOPROTEINEMIA	0.05772	2.1218935186630135
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.05772	2.1218935186630135
NIEMANN-PICK DISEASE, TYPE B	0.05772	2.1218935186630135
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.05772	2.1218935186630135
FISH-EYE DISEASE	0.05772	2.1218935186630135
ATHEROSCLEROSIS SUSCEPTIBILITY	0.05772	2.1218935186630135
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.05772	2.1218935186630135
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.057486689	2.1133165765505257
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.107534343188485
DOORS SYNDROME	0.057079424	2.0983447649795224
MEIER-GORLIN SYNDROME 1; MGORS1	0.056680180000000004	2.0836678201429826
EPISODIC ATAXIA, TYPE 6	0.056292618999999995	2.0694203639062088
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.056224778999999996	2.0669264405467827
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.056031329	2.0598148622171677
WILSON DISEASE	0.056005400000000004	2.0588616644166584
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.055861654	2.0535772966804537
SPINOCEREBELLAR ATAXIA 26	0.055651110000000004	2.045837311424158
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0423261878973475
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0423261878973475
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0423261878973475
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0423261878973475
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0423261878973475
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0423261878973475
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0423261878973475
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0423261878973475
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0423261878973475
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0423261878973475
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.055135553000000004	2.0268844864622495
TEMPLE SYNDROME	0.054048580000000006	1.9869253568076815
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.05385859	1.9799409744512921
XQ12-Q13.3 DUPLICATION SYNDROME	0.053784269999999995	1.9772088343558825
EPISODIC ATAXIA, TYPE 2	0.053571499999999994	1.9693870172393553
ERYTHERMALGIA, PRIMARY	0.05307093	1.9509851420030921
SPINOCEREBELLAR ATAXIA 18	0.053010949999999994	1.9487801667215705
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.052944093000000005	1.9463223802528036
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.052718293	1.9380215563353724
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9348345619692349
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	1.9348345619692349
KNIEST-LIKE DYSPLASIA, LETHAL	0.0526316	1.9348345619692349
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	1.9348345619692349
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	1.9348345619692349
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9348345619692349
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9348345619692349
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.05161315	1.89739446401216
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.05161315	1.89739446401216
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.051563308999999995	1.8955622170464
CHROMOSOME 17Q12 DELETION SYNDROME	0.05138562	1.889030042108117
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.05137010999999999	1.88845986593912
16P13.2 MICRODELETION SYNDROME	0.051332073	1.8870615557560058
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.8815122086628622
ADRENOLEUKODYSTROPHY	0.051064319000000004	1.8772184255204531
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.050545554	1.8581476685694966
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.050541419000000004	1.8579956583529396
NEUROLEPTIC MALIGNANT SYNDROME	0.05	1.838092098633934
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.05	1.838092098633934
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.049932963000000004	1.8356276950336112
XP22.13P22.2 DUPLICATION SYNDROME	0.049886718999999996	1.8339276804134268
ALG13-CDG	0.049802	1.8308132539233433
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.049758734	1.8292227160685535
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.049627554000000004	1.8244002976385776
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.049585960000000005	1.822871225583566
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.049556133	1.8217747301230471
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.049335500000000004	1.813663854643089
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.049114434	1.8055370612855566
COG5-CDG	0.049108719	1.805326967358683
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8041555512642231
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04907410999999999	1.80405467676985
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.049064204	1.803690513963269
LISSENCEPHALY, X-LINKED, 2	0.048938699	1.7990767189864878
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04893246	1.7988473618544203
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.04884065	1.7954722571429087
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.048708949999999994	1.7906307225551068
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.048705973	1.7905212825515542
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.04869111400000001	1.7899750383416826
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.048388319	1.7788437364015652
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.048388319	1.7788437364015652
DISTAL 17P13.1 MICRODELETION SYNDROME	0.04820264999999999	1.7720182019643396
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.048160419	1.7704657126159917
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.048160419	1.7704657126159917
HAMAMY SYNDROME; HMMS	0.04811831	1.7689177082123637
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.048022503	1.7653956664184876
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.047892103000000005	1.7606019222252505
SPINOCEREBELLAR ATAXIA 2; SCA2	0.04788794	1.760448882677118
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.047643704	1.751470317441079
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.047619	1.750562152896986
APOLIPOPROTEIN A-I DEFICIENCY	0.047619	1.750562152896986
HYPERLIPOPROTEINEMIA, TYPE V	0.047619	1.750562152896986
TANGIER DISEASE; TGD	0.047619	1.750562152896986
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.047619	1.750562152896986
FISH-EYE DISEASE	0.047619	1.750562152896986
SPINOCEREBELLAR ATAXIA 42	0.047619	1.750562152896986
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.047619	1.750562152896986
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.047619	1.750562152896986
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.047619	1.750562152896986
TURNPENNY-FRY SYNDROME; TPFS	0.047499794	1.7461799207627908
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04747941	1.7454305673760198
MENTAL RETARDATION, X-LINKED 98; MRX98	0.04745448299999999	1.7445142049411662
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0474338	1.7437538597636457
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.04731445	1.7393663339242065
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.04713263299999999	1.7326824061022599
SALT-AND-PEPPER SYNDROME	0.047118603999999994	1.7321666742212254
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.046734039000000005	1.7180293564630023
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7170632920178022
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.046506589999999993	1.709667912268158
MALAN OVERGROWTH SYNDROME	0.046256699	1.7004814588157637
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.045832329000000005	1.6848808359378182
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.682775301438833
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04571528	1.680577899096758
HALLERMANN-STREIFF SYNDROME; HSS	0.04550375	1.6728016666642773
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.045467169	1.6714568817230748
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.045179024	1.6608641407678573
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.045062889999999994	1.656594841012202
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04504809	1.6560507657510066
MICROHYDRANENCEPHALY; MHAC	0.04497356	1.653310905668783
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6515444991619954
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.044913110000000006	1.6510886523215345
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.6338583769889399
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.04437731899999999	1.6313919882491508
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.044202130000000006	1.6249517179157995
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04407925	1.6204344227741967
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	1.6183979637762782
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.6182459535597211
LASSA FEVER	0.044019719000000006	1.6182459535597211
KEUTEL SYNDROME; KTLS	0.044019719000000006	1.6182459535597211
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6182459535597211
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.044019003	1.6182196320808684
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.043980662999999996	1.616810183059636
CHROMOSOME 1P36 DELETION SYNDROME	0.043823392999999995	1.6110286481725928
QAZI-MARKOUIZOS SYNDROME	0.043812239	1.6106186065872299
PGM3-CDG	0.043685219	1.60594911741986
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.043631804	1.6039854836308893
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.5983423938407153
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	1.5983423938407153
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.5983423938407153
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.5983423938407153
YELLOW FEVER	0.043478300000000004	1.5983423938407153
ASHERMAN SYNDROME	0.043478300000000004	1.5983423938407153
HYDATIDIFORM MOLE	0.043478300000000004	1.5983423938407153
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.5983423938407153
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.5983423938407153
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.5983423938407153
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.5983423938407153
WERNER SYNDROME	0.043478300000000004	1.5983423938407153
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.04343510899999999	1.5967546131240729
49,XXXYY SYNDROME	0.04329801999999999	1.5917149689698804
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.043297969000000006	1.5917130941159403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.589903860063255
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.043195623999999995	1.5879507033992462
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.04316571	1.5868510096584756
EPISODIC ATAXIA, TYPE 8	0.043143799999999996	1.586045557700854
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.585233488611678
PEHO SYNDROME	0.04305578399999999	1.5828099274177867
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.042985614000000005	1.5802303489665641
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.04289368999999999	1.576851053405067
49,XYYYY SYNDROME	0.04289368999999999	1.576851053405067
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5718095343969347
HARTNUP DISORDER	0.04275367299999999	1.571703770577579
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0423591	1.5571985403048931
COG2-CDG	0.04221225399999999	1.5518002108585731
DISTAL MONOSOMY 12Q	0.04221225399999999	1.5518002108585731
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.042208118999999995	1.551648200642016
EPISODIC ATAXIA TYPE 3	0.042208118999999995	1.551648200642016
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.042208118999999995	1.551648200642016
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.551648200642016
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0422078	1.5516364736144268
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.0422078	1.5516364736144268
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0422078	1.5516364736144268
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0422078	1.5516364736144268
19P13.3 MICRODUPLICATION SYNDROME	0.04217420399999999	1.5504014227715126
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04216521	1.5500707867648107
3P25.3 MICRODELETION SYNDROME	0.04201393	1.5445094553111838
ZELLWEGER SYNDROME	0.04193561900000001	1.5416305987044616
GABRIELE-DE VRIES SYNDROME	0.04189021	1.539961280222324
EPISODIC ATAXIA, TYPE 7; EA7	0.041666699999999994	1.5317446409230102
EPISODIC ATAXIA, TYPE 5	0.041666699999999994	1.5317446409230102
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.041666699999999994	1.5317446409230102
EPISODIC ATAXIA, TYPE 3	0.041666699999999994	1.5317446409230102
HISTIDINEMIA	0.041666699999999994	1.5317446409230102
EPISODIC ATAXIA TYPE 7	0.041666699999999994	1.5317446409230102
EPISODIC ATAXIA, TYPE 4	0.041666699999999994	1.5317446409230102
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5317446409230102
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.04152505	1.5265373260075807
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.041469549999999994	1.5244970437780967
SPINOCEREBELLAR ATAXIA TYPE 6	0.04142321	1.522793500021083
3Q13 MICRODELETION SYNDROME	0.041319810000000005	1.5189923255611082
SHPRINTZEN OMPHALOCELE SYNDROME	0.04131981	1.518992325561108
PITT-HOPKINS SYNDROME	0.041309859000000004	1.5186265084716382
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.041085580000000003	1.5103815993158476
300270 ADRENOMYODYSTROPHY	0.040936193999999995	1.5048898947909168
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.040697983	1.4961328196527632
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.040566594	1.4913027179978147
ACROCEPHALOPOLYDACTYLY	0.04009282	1.4738859130790511
245800 LAURENCE-MOON SYNDROME	0.039938600000000005	1.4682165018100248
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.03988436	1.4662225395014266
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.03988436	1.4662225395014266
DEND SYNDROME	0.039841769	1.464656815889968
16P13.11 MICRODELETION SYNDROME	0.039751754	1.4613476986847975
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.03974095999999999	1.4609508913625442
VELOCARDIOFACIAL SYNDROME	0.03968849	1.4590219975142378
MACHADO-JOSEPH DISEASE; MJD	0.039514600000000004	1.4526294808136089
MOEBIUS SYNDROME; MBS	0.03935279999999999	1.4466814147824292
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4437147341352343
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.039119583	1.438107928283087
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.039009459999999996	1.4340596039595297
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.039002919000000004	1.4338191447511868
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.038970473000000005	1.4326263700265411
LISSENCEPHALY 2; LIS2	0.038809543999999994	1.4267103235597196
9Q31.1Q31.3 MICRODELETION SYNDROME	0.038709709999999994	1.4230402418282193
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.038709709999999994	1.4230402418282193
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.038599784	1.4189991595875306
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4161139431821468
MYOCLONUS AND ATAXIA	0.0385141	1.4158492579199438
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0384747	1.4144008413462203
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	1.413915585032181
WIDOW'S PEAK SYNDROME	0.0384615	1.413915585032181
BAZEX SYNDROME; BZX	0.0384615	1.413915585032181
MAL DE MELEDA	0.0384615	1.413915585032181
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	1.413915585032181
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.413915585032181
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.413915585032181
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0384615	1.413915585032181
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.413915585032181
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.413915585032181
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.413915585032181
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.413915585032181
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.413915585032181
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0384615	1.413915585032181
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	1.413915585032181
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.413915585032181
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.413915585032181
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0384615	1.413915585032181
MUCOLIPIDOSIS III GAMMA	0.0384615	1.413915585032181
MYCETOMA	0.0384615	1.413915585032181
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.413915585032181
CYCLIC NEUTROPENIA	0.0384615	1.413915585032181
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	1.413915585032181
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.413915585032181
BLACKFAN-DIAMOND ANEMIA	0.0384615	1.413915585032181
LIP, HAMARTOMATOUS	0.0384615	1.413915585032181
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.413915585032181
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.413915585032181
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.413915585032181
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.038424919	1.4125708000909782
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.038424919	1.4125708000909782
CANAVAN DISEASE	0.03826399	1.4066547536241572
CEREBROFACIOARTICULAR SYNDROME	0.038136774	1.4019780591357607
ALPERS-HUTTENLOCHER SYNDROME	0.038069694	1.3995120747762335
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.037927729	1.3942931798805822
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.392658417529899
YOU-HOOVER-FONG SYNDROME; YHFS	0.037736954	1.3872799394782447
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0376773	1.3850869485572062
16P12.1P12.3 TRIPLICATION SYNDROME	0.03749473	1.378375339068254
PITT-HOPKINS-LIKE SYNDROME	0.037360629	1.373445539297876
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.037254764	1.3695537468974386
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.037106214000000005	1.3640927752723973
MCLEOD SYNDROME; MCLDS	0.037037	1.3615483411421
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3615483411421
DISTAL 16P11.2 MICRODELETION SYNDROME	0.037034723	1.3614646344279284
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.3528825824194064
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.036784003999999995	1.3522477421703802
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.3450201802293418
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03630668	1.3347004327126135
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715	1.3343500923586138
SLC39A8-CDG	0.036255719000000006	1.332827012483844
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.036255719000000006	1.332827012483844
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.036255719000000006	1.332827012483844
OROFACIODIGITAL SYNDROME TYPE 14	0.036255344	1.3328132267931039
PMM2-CDG	0.036134143	1.3283576547841733
THUMBS, CONGENITAL CLASPED	0.0361093	1.327444380344046
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03604598	1.325116620510336
OCULODENTODIGITAL DYSPLASIA	0.035907939	1.3200419790825857
SPINOCEREBELLAR ATAXIA TYPE 13	0.035807283	1.3163416791169837
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3111570462580506
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3111570462580506
SPINOCEREBELLAR ATAXIA TYPE 23	0.03566016	1.3109331666404374
SPINOCEREBELLAR ATAXIA TYPE 35	0.03566016	1.3109331666404374
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035569773	1.3076103740300526
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.035297193	1.29758983114514
INHERITED CREUTZFELDT-JAKOB DISEASE	0.035118329000000004	1.291014461042539
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.035028354	1.2877068143110468
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.034833334	1.2805375198895352
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.2800491755807704
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.03475615	1.277700093878716
SPINOCEREBELLAR ATAXIA TYPE 1	0.03461275	1.2724284457398336
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.03461275	1.2724284457398336
SPINOCEREBELLAR ATAXIA 12	0.03461275	1.2724284457398336
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	1.2676512443754844
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.034434974	1.265893072521299
MEIER-GORLIN SYNDROME 5; MGORS5	0.034427299999999994	1.2656109621460003
ISOTRETINOIN-LIKE SYNDROME	0.034427299999999994	1.2656109621460003
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.034313750000000004	1.261436654990003
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.034313750000000004	1.261436654990003
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.034299293	1.260905189040604
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.034276618999999994	1.2600716510357153
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.034147369	1.2553201829607465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.034030644	1.2510291569564858
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.034005934	1.250120771841341
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.033889419999999996	1.245837502585736
9P13 MICRODELETION SYNDROME	0.033889419999999996	1.245837502585736
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.033889419999999996	1.245837502585736
HOLMES-GANG SYNDROME	0.033757874	1.2410016293215982
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.033755623000000005	1.2409188784153178
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.033485089999999995	1.2309735870209229
DENT DISEASE	0.033485089999999995	1.2309735870209229
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.033485089999999995	1.2309735870209229
RAMOS-ARROYO SYNDROME	0.03346038	1.230065201905778
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.033369719	1.226732336550693
GLYCOGEN STORAGE DISEASE VI	0.0333568	1.226257410314248
EPILEPSY, PYRIDOXINE-DEPENDENT	0.033356234	1.2262366031116916
SPINOCEREBELLAR ATAXIA 34; SCA34	0.03330541	1.224368219255272
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.033283113	1.2235485404648074
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0332372	1.2218606940143157
ANAL SPHINCTER DYSPLASIA; ASDP	0.032983229999999995	1.2125242890085142
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.032830709	1.2069173361089995
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2059227444744285
HYDROXYKYNURENINURIA	0.032803653999999995	1.2059227444744285
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2059227444744285
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2059227444744285
TUBEROUS SCLEROSIS-1	0.032799519	1.2057707342578716
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2057707342578716
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2057707342578716
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.032738010000000005	1.2035095501199744
SPINOCEREBELLAR ATAXIA TYPE 36	0.03271165	1.2025405079655744
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.032652640000000004	1.200371191670767
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.032487842999999995	1.194312950399195
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.1858671745388658
DYSTONIA, JUVENILE-ONSET	0.0322581	1.1858671745388658
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.1858671745388658
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.1858671745388658
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.1858671745388658
WEST SYNDROME	0.0322581	1.1858671745388658
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.1858671745388658
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.1858671745388658
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.1858671745388658
SECKEL SYNDROME 2; SCKL2	0.0322581	1.1858671745388658
DESMOID TUMOR	0.0322581	1.1858671745388658
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.1858671745388658
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.1858671745388658
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.1858671745388658
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.1858671745388658
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.1858671745388658
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.1858671745388658
SECKEL SYNDROME	0.0322581	1.1858671745388658
THROMBOCYTOPENIA 1	0.0322581	1.1858671745388658
COG1-CDG	0.0322581	1.1858671745388658
INFANTILE MYOFIBROMATOSIS	0.0322581	1.1858671745388658
MILD CANAVAN DISEASE	0.0322581	1.1858671745388658
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.1858671745388658
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.03195515	1.174730174513243
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.031842644	1.1705942467202648
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.031725763	1.1662974858686561
15Q13.3 MICRODELETION SYNDROME	0.031723083000000006	1.1661989641321697
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.031529989999999994	1.1591005097801386
NARP SYNDROME	0.031389972999999995	1.1539532269526502
SPINOCEREBELLAR ATAXIA 27; SCA27	0.03126091	1.1492086333421307
SPINOCEREBELLAR ATAXIA 15	0.03126091	1.1492086333421307
SPINOCEREBELLAR ATAXIA TYPE 27	0.03126091	1.1492086333421307
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1479587307150592
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.03111751	1.1439369852032484
HUNTINGTON DISEASE-LIKE 1	0.03096915	1.138482998328182
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.1338976570170876
HUNTINGTON DISEASE-LIKE 3	0.030844418999999998	1.1338976570170876
2Q24 MICRODELETION SYNDROME	0.030676128999999996	1.1277110066315055
8P INVERTED DUPLICATION/DELETION SYNDROME	0.030676128999999996	1.1277110066315055
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.030546778999999996	1.1229558623723395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.030439623	1.1190166104339152
NORMAL PRESSURE HYDROCEPHALUS	0.030302999999999997	1.1139940972980817
CARIBBEAN PARKINSONISM	0.030302999999999997	1.1139940972980817
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.1139940972980817
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.1139940972980817
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03024371	1.1118144876875218
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.030213499999999997	1.110703912441527
GLYCINE ENCEPHALOPATHY	0.030092559999999997	1.1062579352733515
CURRY-JONES SYNDROME	0.029957354	1.1012875136675933
CURRARINO SYNDROME	0.029957354	1.1012875136675933
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.029953219	1.1011355034510364
HUNTINGTON DISEASE-LIKE 1	0.029792479000000004	1.0952264049723481
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.0922300942805228
SPINOCEREBELLAR ATAXIA TYPE 3	0.0294487	1.0825884557008225
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	1.0812319437320306
VARIANT ABETA2M AMYLOIDOSIS	0.0294118	1.0812319437320306
AL AMYLOIDOSIS	0.0294118	1.0812319437320306
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.029263249999999998	1.0757709721069892
STICKLER SYNDROME, TYPE II	0.029263249999999998	1.0757709721069892
MENINGIOMA	0.0292549	1.0754640107265174
SPINOCEREBELLAR ATAXIA TYPE 43	0.029081210000000003	1.069078846394283
SPINOCEREBELLAR ATAXIA TYPE 14	0.029081210000000003	1.069078846394283
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.029004790000000003	1.0662695064307308
OSTEOPENIA AND SPARSE HAIR	0.029004790000000003	1.0662695064307308
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0522709646259543
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0522709646259543
SPINOCEREBELLAR ATAXIA TYPE 29	0.028381714	1.043364084981762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.028381714	1.043364084981762
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0412186638842365
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0412186638842365
MENKES DISEASE	0.028319219000000003	1.0410666536676796
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.02783616	1.0233085150461991
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.02783616	1.0233085150461991
SPINOCEREBELLAR ATAXIA TYPE 40	0.02783616	1.0233085150461991
SPINOCEREBELLAR ATAXIA 44; SCA44	0.02783616	1.0233085150461991
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0211630939486738
DIMPLES, FACIAL	0.027777800000000002	1.0211630939486738
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0211630939486738
OROFACIAL CLEFT 3	0.027777800000000002	1.0211630939486738
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0211630939486738
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0211630939486738
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0211630939486738
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0211630939486738
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0211630939486738
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0211630939486738
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0211630939486738
DWARFISM, LEVI TYPE	0.027777800000000002	1.0211630939486738
GANGLIOCYTOMA	0.027777800000000002	1.0211630939486738
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0211630939486738
CLEFT CHIN	0.027777800000000002	1.0211630939486738
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0211630939486738
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0211630939486738
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0211630939486738
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0211630939486738
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0211630939486738
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.0211630939486738
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0211630939486738
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0211630939486738
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0211630939486738
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0211630939486738
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0211630939486738
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0211630939486738
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0211630939486738
19P13.13 MICRODELETION SYNDROME	0.027614793	1.0151706563742333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0136178729311491
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.027369249999999998	1.0061440434107358
ACUTE INTERMITTENT PORPHYRIA	0.027368649000000002	1.0061219495437101
TRISOMY 20P	0.02724851	1.0017054186109546
19P13.12 MICRODELETION SYNDROME	0.027201082999999997	0.9999619147317164
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9935623029955866
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9935623029955866
BENIGN OCCIPITAL EPILEPSY	0.027027	0.9935623029955866
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9935623029955866
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.026954273	0.9908887245144395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.026954273	0.9908887245144395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.026954273	0.9908887245144395
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.02672351	0.9824054515752982
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.026678254000000002	0.9807417576549827
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.026678254000000002	0.9807417576549827
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.026672582999999996	0.9805332812491555
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.026511973	0.9746289618099239
HAREL-YOON SYNDROME; HAYOS	0.026159503999999997	0.9616715521316556
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026148953999999995	0.9612837146988438
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.026132700000000002	0.96068618771942
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.026132700000000002	0.96068618771942
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.026132700000000002	0.96068618771942
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.026132700000000002	0.96068618771942
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.026132700000000002	0.96068618771942
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.026124354	0.9603793733863161
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.025983473	0.955200328327363
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.025964123	0.9544889866851918
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0258673	0.950929594859871
GRISCELLI SYNDROME TYPE 1	0.025819873	0.9491860909806329
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.025512959999999998	0.937903403775272
KAGAMI-OGATA SYNDROME	0.025491703	0.937121957300459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.025477173000000002	0.936587807736596
TETRASOMY 5P	0.025445593	0.9354268687670987
CK SYNDROME	0.025445593	0.9354268687670987
GABRIELE-DE VRIES SYNDROME; GADEVS	0.025442054	0.9352967686083574
SPINOCEREBELLAR ATAXIA TYPE 7	0.025422703999999997	0.934585426966186
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.025024209000000002	0.9199360167492836
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.024935754	0.9166842480175902
COHEN-GIBSON SYNDROME; COGIS	0.024904173999999998	0.9155233090480929
LAMB-SHAFFER SYNDROME	0.024904173999999998	0.9155233090480929
TURNER SYNDROME	0.02488712	0.9148963725950908
MOSAIC MONOSOMY X	0.02488712	0.9148963725950908
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.02488712	0.9148963725950908
MONOSOMY X	0.02488712	0.9148963725950908
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.02488188	0.9147037405431541
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.024778583	0.9109063525529024
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9091282190185257
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.024495708999999997	0.9005073832667227
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.02448279	0.9000324570302778
SPINOCEREBELLAR ATAXIA TYPE 5	0.0243902	0.8966286780820275
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0243902	0.8966286780820275
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0243902	0.8966286780820275
ORAL SENSIBILITY, DISTURBANCE OF	0.0243902	0.8966286780820275
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.024358619999999997	0.8954677391125302
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.024357674	0.8954329624100241
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.024342773	0.8948851742027893
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.024233029	0.8908507826173395
KAGAMI-OGATA SYNDROME	0.023814273	0.8754565407202285
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.023814273	0.8754565407202285
MEND SYNDROME; MEND	0.023814273	0.8754565407202285
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.023814273	0.8754565407202285
CHROMOSOME 5Q12 DELETION SYNDROME	0.023814273	0.8754565407202285
INFANTILE LIVER FAILURE SYNDROME 1	0.023814273	0.8754565407202285
MEND SYNDROME	0.023814273	0.8754565407202285
GRISCELLI SYNDROME TYPE 2	0.023797219	0.8748296042672266
FAMILIAL MULTIPLE LIPOMATOSIS	0.023797219	0.8748296042672266
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.023794922999999996	0.874745199078057
SPINOCEREBELLAR ATAXIA 46; SCA46	0.023755360000000003	0.8732907903240923
SPINOCEREBELLAR ATAXIA 23; SCA23	0.023755360000000003	0.8732907903240923
FRIEDREICH ATAXIA	0.023755360000000003	0.8732907903240923
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.023755360000000003	0.8732907903240923
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.023716803999999998	0.8718734007449933
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.02369301	0.8709986894770957
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.023636903	0.8689360928095345
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.02361196	0.86801914218521
SPINOCEREBELLAR ATAXIA 14	0.023611959999999998	0.8680191421852099
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.023611959999999998	0.8680191421852099
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.023551593	0.8657999400708452
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.023468313999999997	0.8627384506332025
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.023444939999999997	0.8618791793389331
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8618721945889583
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.023397373	0.8601305288018187
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.023343759999999998	0.8581596161681375
RETT SYNDROME; RTT	0.023325559	0.8574905138823928
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.023272854	0.8555529810012228
CHROMOSOME 15Q25 DELETION SYNDROME	0.023272854	0.8555529810012228
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.023272854	0.8555529810012228
SWEENEY-COX SYNDROME; SWCOS	0.023272854	0.8555529810012228
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.023268719	0.8554009707846657
EDINBURGH MALFORMATION SYNDROME	0.023268719	0.8554009707846657
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0232558	0.8549260445482207
MICROTRIPLICATION 11Q24.1	0.0232558	0.8549260445482207
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.0232558	0.8549260445482207
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.0232558	0.8549260445482207
GLYCOGEN STORAGE DISEASE IA	0.0232558	0.8549260445482207
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.0232558	0.8549260445482207
PRIMARY LIPODYSTROPHY	0.0232558	0.8549260445482207
GLYCOGEN STORAGE DISEASE IB	0.0232558	0.8549260445482207
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.0232558	0.8549260445482207
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0232558	0.8549260445482207
CHOLESTEROL-ESTER TRANSFER PROTEIN DEFICIENCY	0.0232558	0.8549260445482207
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0232558	0.8549260445482207
AROMATASE DEFICIENCY	0.0232558	0.8549260445482207
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0232558	0.8549260445482207
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0232558	0.8549260445482207
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.0232558	0.8549260445482207
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.0232558	0.8549260445482207
HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3	0.0232558	0.8549260445482207
WOODHOUSE-SAKATI SYNDROME	0.0232558	0.8549260445482207
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0232558	0.8549260445482207
WOODHOUSE-SAKATI SYNDROME	0.0232558	0.8549260445482207
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.023249369	0.8546896291424944
GAUCHER DISEASE	0.02305418	0.8475141219696893
COSTELLO SYNDROME; CSTLO	0.023010173999999998	0.8458963803518394
CHROMOSOME 16Q22 DELETION SYNDROME	0.023010173999999998	0.8458963803518394
RENPENNING SYNDROME 1; RENS1	0.023006039	0.8457443701352825
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.02297406	0.8445687631908384
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.022949303999999997	0.8436586870309624
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0227273	0.83549741106566
SOTOS SYNDROME 2	0.0227273	0.83549741106566
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0227273	0.83549741106566
SPONDYLOOCULAR SYNDROME; SOS	0.0227273	0.83549741106566
FRONTOMETAPHYSEAL DYSPLASIA	0.0227273	0.83549741106566
ATAXIA WITH VITAMIN E DEFICIENCY	0.022707949999999998	0.8347860694234887
SPINOCEREBELLAR ATAXIA 40; SCA40	0.022707949999999998	0.8347860694234887
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.022707949999999998	0.8347860694234887
NEPHROSIALIDOSIS	0.02265578	0.8328682041277741
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	0.8328682041277741
SPINAL ARACHNOIDITIS	0.02265578	0.8328682041277741
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	0.8328682041277741
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02265578	0.8328682041277741
OCCIPITAL HORN SYNDROME	0.022605844	0.8310324647870263
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.022601709	0.8308804545704694
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8276268477466774
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8276268477466774
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8276268477466774
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8276268477466774
COSTELLO SYNDROME	0.022464619999999998	0.8258408104162767
XQ21 MICRODELETION SYNDROME	0.022344182999999997	0.8214133244546131
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.022277173	0.8189499134240241
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.02206029	0.8109768948514636
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021920273	0.8058296120239752
PRADER-WILLI SYNDROME; PWS	0.021920273	0.8058296120239752
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021750423	0.7995856131649156
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.021385449	0.7861684966527792
COFFIN-SIRIS SYNDROME 8; CSS8	0.021374719	0.7857740420884123
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.021374719	0.7857740420884123
X-LINKED ADRENOLEUKODYSTROPHY	0.02133178	0.7841955253559475
COFFIN-LOWRY SYNDROME	0.021307329	0.7832966615578736
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7825274200145952
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.02125721	0.7814541948000449
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02125721	0.7814541948000449
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.02125721	0.7814541948000449
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.021251304	0.7812370793613542
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.021209004	0.7796820534459099
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.021209004	0.7796820534459099
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.02112675	0.7766582448962892
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7730750681592122
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7730750681592122
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7730750681592122
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7730750681592122
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7730750681592122
TRANSALDOLASE DEFICIENCY	0.0208333	0.7658704823694066
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0208333	0.7658704823694066
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0208333	0.7658704823694066
CLEFT LIP/PALATE	0.0208333	0.7658704823694066
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0208333	0.7658704823694066
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.0208333	0.7658704823694066
RIBOFLAVIN DEFICIENCY	0.0208333	0.7658704823694066
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0208333	0.7658704823694066
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0208333	0.7658704823694066
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7624718500790324
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7624718500790324
AYMÉ-GRIPP SYNDROME	0.020695764	0.7608144056718523
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.02066345	0.7596264835103472
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.020604439999999998	0.7574571672155394
MULTIPLE SYSTEM ATROPHY	0.020604439999999998	0.7574571672155394
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020580274000000003	0.7565687805424277
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.02053611	0.7549452305535462
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.7535890862031741
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.02024799	0.744353408644378
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.020080339	0.7381902490758165
SMITH-MAGENIS SYNDROME	0.020034973000000005	0.7365225113528842
BAND HETEROTOPIA; BH	0.019954873	0.7335778878108725
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7335778878108725
PITT-HOPKINS SYNDROME	0.019634413	0.7217971879323078
BRAIN-LUNG-THYROID SYNDROME	0.019566554	0.7193025660978838
RIDDLE SYNDROME	0.019566554	0.7193025660978838
PERMANENT NEONATAL DIABETES MELLITUS	0.019551154	0.7187364337315046
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7135223178753097
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7135223178753097
HHHH SYNDROME	0.019409319	0.7135223178753097
COHEN SYNDROME	0.019350103	0.7113454286410555
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.019294964	0.7093184174365241
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.019259024	0.7079971968360259
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.019251964	0.7077376582316989
UROCANIC ACIDURIA	0.01921271	0.7062946088869033
MARINESCO-SJOGREN SYNDROME; MSS	0.019199064000000002	0.7057929567913442
FRAXE INTELLECTUAL DISABILITY	0.01917522	0.7049164074313475
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.019117253999999997	0.7027854704995592
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.019114733999999998	0.702692830657788
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.019021	0.6992469961623211
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.019016264	0.6990728920787386
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.693618758156304
TOE, MISSHAPEN	0.0188679	0.693618758156304
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.693618758156304
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.693618758156304
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.693618758156304
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.693618758156304
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.693618758156304
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.693618758156304
VESICOURETERAL REFLUX 1	0.0188679	0.693618758156304
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.693618758156304
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.693618758156304
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.693618758156304
CARPAL DISPLACEMENT	0.0188679	0.693618758156304
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.693618758156304
VAN DEN BOSCH SYNDROME	0.0188679	0.693618758156304
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.693618758156304
THROMBOCYTOPENIA 3	0.0188679	0.693618758156304
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.693618758156304
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.693618758156304
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.693618758156304
KNUCKLE PADS	0.0188679	0.693618758156304
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.693618758156304
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.693618758156304
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.693618758156304
LETTERER-SIWE DISEASE	0.0188679	0.693618758156304
MONOPHALANGY OF GREAT TOE	0.0188679	0.693618758156304
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.693618758156304
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.693618758156304
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.693618758156304
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.693618758156304
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.693618758156304
RAYNAUD DISEASE	0.0188679	0.693618758156304
PUBIC BONE DYSPLASIA	0.0188679	0.693618758156304
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.693618758156304
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.693618758156304
TRACHEOBRONCHOMEGALY	0.0188679	0.693618758156304
SPINOCEREBELLAR ATAXIA 31	0.01865351	0.6857373868557815
ADULT-ONSET DYSTONIA-PARKINSONISM	0.018630873000000003	0.684905209039046
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01853655	0.6814377218186568
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6814377218186568
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.01848375	0.6794966965624994
MOSAIC TRISOMY 15	0.01846839	0.6789320346697991
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.018442962999999996	0.6779972913139597
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.018409494000000002	0.6767669092249763
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.018292733999999998	0.6724745965562462
22Q11.2 DELETION SYNDROME	0.018101243	0.665435034675056
TENORIO SYNDROME; TNORS	0.018085319000000002	0.6648496391034833
TRANSIENT NEONATAL DIABETES MELLITUS	0.018074054	0.6644355169536609
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.018046739	0.6634313672401772
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.01794591	0.6597247074759139
AMISH LETHAL MICROCEPHALY	0.01784585	0.6560463175681277
X SMALL RINGS	0.017839934	0.6558288345110173
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017815584	0.6549336836589826
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.017717829	0.6513400297969435
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.017578563999999998	0.6462203918746183
JUVENILE HUNTINGTON DISEASE	0.017574429	0.6460683816580614
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.0175439	0.6449460793844775
MYOPATHY, DISTAL 3	0.0175439	0.6449460793844775
PANDAS	0.0175439	0.6449460793844775
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0175439	0.6449460793844775
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.0175439	0.6449460793844775
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0175439	0.6449460793844775
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.0175439	0.6449460793844775
DISTAL MYOPATHY, TATEYAMA TYPE	0.0175439	0.6449460793844775
DYSTONIA 7, TORSION	0.0175439	0.6449460793844775
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0175439	0.6449460793844775
EPISODIC ATAXIA TYPE 1	0.0175439	0.6449460793844775
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.0175439	0.6449460793844775
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0175439	0.6449460793844775
TIBIAL MUSCULAR DYSTROPHY	0.0175439	0.6449460793844775
DISTAL MYOPATHY, WELANDER TYPE	0.0175439	0.6449460793844775
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.0175439	0.6449460793844775
MELAS	0.01736635	0.6384190143422284
ALCOHOL DEPENDENCE	0.0172414	0.6338256221877422
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6338256221877422
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6338256221877422
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6338256221877422
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6338256221877422
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6338256221877422
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6338256221877422
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6338256221877422
PALMOMENTAL REFLEX	0.0172414	0.6338256221877422
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6338256221877422
RHEUMATOID ARTHRITIS	0.0172414	0.6338256221877422
MOTION SICKNESS	0.0172414	0.6338256221877422
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6338256221877422
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6338256221877422
SICKLE CELL ANEMIA	0.0172414	0.6338256221877422
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6338256221877422
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6338256221877422
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6338256221877422
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6338256221877422
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6338256221877422
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6338256221877422
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6338256221877422
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6338256221877422
CERVICAL RIB	0.0172414	0.6338256221877422
TRANSSEXUALITY	0.0172414	0.6338256221877422
CARDIAC ARRHYTHMIA	0.0172414	0.6338256221877422
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6338256221877422
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6338256221877422
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6338256221877422
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6338256221877422
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6338256221877422
MYOPATHY, CONGENITAL	0.0172414	0.6338256221877422
DIASTEMATOMYELIA	0.0172414	0.6338256221877422
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6338256221877422
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6338256221877422
269800 SENILE PLAQUE FORMATION	0.0172414	0.6338256221877422
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6338256221877422
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6338256221877422
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6338256221877422
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6338256221877422
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6338256221877422
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6338256221877422
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6338256221877422
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6338256221877422
SPINOCEREBELLAR ATAXIA 20	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA TYPE 8	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA TYPE 28	0.017176410000000003	0.6314364700779378
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA 38; SCA38	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA 45; SCA45	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA TYPE 30	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA 43; SCA43	0.017176410000000003	0.6314364700779378
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.017176410000000003	0.6314364700779378
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.017176410000000003	0.6314364700779378
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.6311296557448337
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.017160279	0.6308434648050765
PYRIDOXINE-DEPENDENT EPILEPSY	0.017054724	0.6269630685756503
SPINOCEREBELLAR ATAXIA TYPE 21	0.017033009999999998	0.6261648219390555
SPINOCEREBELLAR ATAXIA TYPE 2	0.017033009999999998	0.6261648219390555
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.017033009999999998	0.6261648219390555
ARNOLD-CHIARI MALFORMATION TYPE I	0.017033009999999998	0.6261648219390555
SPINOCEREBELLAR ATAXIA TYPE 25	0.017033009999999998	0.6261648219390555
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016948053999999997	0.6230416828924246
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.016877373	0.6204433191399539
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016847064000000002	0.619329104471604
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016847064000000002	0.619329104471604
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.016785239	0.6170563035916431
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.016653979	0.6122309442143092
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.016529213	0.607644316238746
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016413353999999998	0.6033851259896333
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6029861129568619
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.6029861129568619
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.016387633	0.6024395746522541
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016383764000000002	0.602297343085662
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.016375263999999997	0.601984867428894
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.016371073	0.6018307985491865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.016301509999999998	0.5992735345360412
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.5992735345360412
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.5992735345360412
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01629358	0.5989820131291977
PRIMARY DYSTONIA, DYT4 TYPE	0.016128999999999998	0.5929317491773343
OPTIC ATROPHY 2	0.016128999999999998	0.5929317491773343
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.016128999999999998	0.5929317491773343
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.016128999999999998	0.5929317491773343
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.016128999999999998	0.5929317491773343
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.01584163	0.5823674986496457
PEHO-LIKE SYNDROME; PEHOL	0.015840373999999997	0.5823213257761279
PROPIONIC ACIDEMIA	0.015749232999999998	0.578970814736896
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015721253999999997	0.5779422551603424
MONOSOMY 18Q	0.015705853	0.5773760860321213
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.015686153999999997	0.5766519145071014
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01567665	0.5763025299609932
MEHMO SYNDROME	0.015627428999999998	0.5744930753372558
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.015536633	0.5711552471335045
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.568740766114581
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.568740766114581
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.568740766114581
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.015426632999999999	0.5671114445165099
DESMOSTEROLOSIS	0.015294819999999999	0.5622657558405653
HYPERPROLINEMIA, TYPE I	0.015285363	0.5619180991010296
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5578866852247798
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.015171473	0.5577312929187612
N-ACETYLASPARTATE DEFICIENCY; NACED	0.015171473	0.5577312929187612
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.015053213999999999	0.5533838742489142
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.014933024	0.548965468462218
EPILEPSY, HOT WATER, 1	0.014925589999999999	0.5486921809289931
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5486851961790182
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5486851961790182
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.014898164	0.5476839506510505
PERLMAN SYNDROME	0.014898164	0.5476839506510505
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.014835992999999999	0.545398430173767
SMITH-MAGENIS SYNDROME; SMS	0.014759403	0.5425828406970796
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.014750472999999998	0.5422545574482635
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014665173	0.5391187723279941
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.014633833	0.5379666562005703
JOUBERT SYNDROME 31; JBTS31	0.014630054	0.5378277331997555
ANGELMAN SYNDROME (TYPE 1)	0.014625919	0.5376757229831985
ANGELMAN SYNDROME (TYPE 2)	0.014625919	0.5376757229831985
WITTEVEEN-KOLK SYNDROME	0.014529813	0.5341426893985723
KOOLEN-DE VRIES SYNDROME	0.014529812999999999	0.5341426893985722
WARBURG MICRO SYNDROME 2; WARBM2	0.01444966	0.5311961174789361
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.014417779	0.5300241131950052
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014378569	0.5285826813712565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5236413383824988
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.014218762999999997	0.5227079184529705
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.01421455	0.5225530408127397
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.014209053999999999	0.5223509977292577
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.014209053999999999	0.5223509977292577
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.014209053999999999	0.5223509977292577
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.014209053999999999	0.5223509977292577
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014209053999999999	0.5223509977292577
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.014209053999999999	0.5223509977292577
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.014166754	0.5207959718138135
DANDY-WALKER SYNDROME	0.0140845	0.5177721632641928
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.0140845	0.5177721632641928
EPISODIC ATAXIA TYPE 5	0.0140845	0.5177721632641928
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.0140845	0.5177721632641928
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.0140845	0.5177721632641928
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0140845	0.5177721632641928
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.014039414	0.5161147188570127
WIEDEMANN-STEINER SYNDROME; WDSTS	0.013968323000000001	0.5135012827493329
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013960649	0.5132191723740346
BANGSTAD SYNDROME	0.013923318999999998	0.5118468528131944
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.013869853	0.5098813441702832
YUNIS-VARON SYNDROME	0.01385902	0.5094831031361933
XQ28 (MECP2) DUPLICATION	0.013835193000000003	0.5086071787275103
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.013756694	0.505721410894497
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.503585768446936
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.503585768446936
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.503585768446936
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.503585768446936
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.503585768446936
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.503585768446936
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.503585768446936
MEVALONIC ACIDURIA; MEVA	0.013677343999999998	0.5028043587339648
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.013671174	0.5025775381689934
RING CHROMOSOME 14 SYNDROME	0.013671173999999998	0.5025775381689934
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671173999999998	0.5025775381689934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013663499999999999	0.502295427793695
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.01364756	0.5017094440326506
ADENYLOSUCCINASE DEFICIENCY	0.013622592999999999	0.5007916111241186
SPINOCEREBELLAR ATAXIA 47; SCA47	0.013571979	0.4989309472545136
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516953999999998	0.49690812689996683
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516953999999998	0.49690812689996683
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.013516953999999998	0.49690812689996683
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516953999999998	0.49690812689996683
KRABBE DISEASE	0.013451114	0.4944877272244857
STICKLER SYNDROME	0.013442840000000001	0.49418355974400385
MOWAT-WILSON SYNDROME	0.013422769000000001	0.49344571281377025
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.013328434	0.4899777844512775
INFANTILE DYSTONIA-PARKINSONISM	0.013328434	0.4899777844512775
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.013324299	0.4898257742347205
KOOLEN-DE VRIES SYNDROME; KDVS	0.013302823000000002	0.4890362769165153
SCHAAF-YANG SYNDROME; SHFYNG	0.013279213	0.4881683298275403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.013279213	0.4881683298275403
FUMARASE DEFICIENCY; FMRD	0.013266844	0.4877136226041802
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013257432999999999	0.48736765690937534
MEHMO SYNDROME; MEHMO	0.013257432999999999	0.48736765690937534
COFS SYNDROME	0.013224399	0.4861532662216499
PEHO SYNDROME; PEHO	0.013218483000000001	0.48593578316453956
TEMPLE-BARAITSER SYNDROME	0.013151579	0.4834762688891994
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.013135173000000002	0.48287315410979575
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.013050322999999999	0.47975391181841387
48,XXYY SYNDROME	0.013042393000000001	0.47946239041157057
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.012991772999999998	0.4776015059709135
RAYNAUD-CLAES SYNDROME; MRXSRC	0.012991772999999998	0.4776015059709135
15Q26 OVERGROWTH SYNDROME	0.012987559999999999	0.4774466283306826
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.4768525569644041
NEONATAL ADRENOLEUKODYSTROPHY	0.012963699	0.47656945401937256
ALLAN-HERNDON-DUDLEY SYNDROME	0.01293309	0.47544421079843086
DISTAL MONOSOMY 10Q	0.012816203	0.47114722937577036
LYSOSOMAL ACID LIPASE DEFICIENCY	0.012815754	0.47113072330872463
6Q TERMINAL DELETION SYNDROME	0.012794133	0.4703358955234333
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.012794133	0.4703358955234333
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.012794133	0.4703358955234333
JABERI-ELAHI SYNDROME; JABELS	0.012794133	0.4703358955234333
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.012794133	0.4703358955234333
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.012761404	0.4691327171975096
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.012751133	0.46875513631860816
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.012737794	0.46826477010853457
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.01272129	0.46765805266861754
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01268503	0.46632506827868814
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.012665073	0.46559141219843947
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.012665073	0.46559141219843947
WHIM SYNDROME	0.012589619000000002	0.46281758417423297
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.012566093	0.46195272507998375
BIOTINIDASE DEFICIENCY	0.012508904	0.45985035209940817
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.012494863000000002	0.45933417907626983
SECONDARY SYRINGOMYELIA	0.012446218999999998	0.4575459360353507
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.012357074	0.45426880163269634
TEMPLE SYNDROME	0.0122702	0.4510751533731619
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.012268599	0.4510162976641636
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.012195779	0.44833930033171315
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.012177803	0.4476784694604123
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.012123654000000001	0.44568785247943377
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.012119519	0.44553584226287674
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.012048200000000002	0.4429140244552273
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.012048200000000002	0.4429140244552273
UNVERRICHT-LUNDBORG DISEASE	0.012048200000000002	0.4429140244552273
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.44260721012212323
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.44260721012212323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.44260721012212323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.44260721012212323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.44260721012212323
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.44260721012212323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.44260721012212323
WIEDEMANN-STEINER SYNDROME	0.012020539	0.44189715514442096
BOWEN-CONRADI SYNDROME	0.011997409	0.4410468537395929
21Q22.11Q22.12 MICRODELETION SYNDROME	0.011997409	0.4410468537395929
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.011997409	0.4410468537395929
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.011997409	0.4410468537395929
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.011974014	0.44018681044664204
WOLF-HIRSCHHORN SYNDROME	0.011958332999999998	0.43961034800266846
MYOPATHY AND DIABETES MELLITUS	0.011904799999999998	0.437642376316345
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.011904799999999998	0.437642376316345
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.011904799999999998	0.437642376316345
SPINOCEREBELLAR ATAXIA TYPE 11	0.011904799999999998	0.437642376316345
SPINOCEREBELLAR ATAXIA TYPE 32	0.011904799999999998	0.437642376316345
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.011904799999999998	0.437642376316345
WOLFRAM-LIKE SYNDROME	0.011904799999999998	0.437642376316345
CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	0.011904799999999998	0.437642376316345
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.011904799999999998	0.437642376316345
PIERPONT SYNDROME	0.011890573	0.4371193655905998
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.011879924	0.4367278887354328
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.011873993	0.4365098542506928
EMANUEL SYNDROME	0.011842473000000001	0.435351120991714
46,XX GONADAL DYSGENESIS	0.01180093	0.43382392379064294
ALG11-CDG	0.011775523	0.43288991567164314
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.011749349	0.4319277112198502
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.011736709	0.4314630415373156
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.011707160000000001	0.430376765868865
SPINOCEREBELLAR ATAXIA 48; SCA48	0.011707160000000001	0.430376765868865
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.011707160000000001	0.430376765868865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.011707160000000001	0.430376765868865
SPINOCEREBELLAR ATAXIA TYPE 18	0.011707160000000001	0.430376765868865
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.011700653	0.43013755656314867
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.011671503	0.4290659488696451
AICARDI-GOUTIERES SYNDROME 5	0.011636384	0.42777490974140653
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.011602803	0.42654041032612205
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.011578100000000001	0.42563228254387103
HOLOPROSENCEPHALY	0.011565293000000003	0.42516147363372697
1P36 DELETION SYNDROME	0.011565293000000003	0.42516147363372697
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.011520259	0.4235059408423293
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.42255164018656044
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.42255164018656044
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.42255164018656044
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.011466443	0.42152756555472753
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.011412779	0.4195547780671057
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.011345019	0.41706379565503704
GLYCOGEN STORAGE DISEASE IXC	0.011327990000000001	0.41643777824808437
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.41643777824808437
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.41643777824808437
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.41643777824808437
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.41643777824808437
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.011281914	0.4147439396173512
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.4145919294007942
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.4145919294007942
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.011237353	0.41310579517720664
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.011229969	0.41283434573608035
XP21 MICRODELETION SYNDROME	0.011187973	0.4112904954205958
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.011187973	0.4112904954205958
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.011187973	0.4112904954205958
GLYCEROL KINASE DEFICIENCY; GKD	0.011187973	0.4112904954205958
ALSTRÖM SYNDROME	0.011187973	0.4112904954205958
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011155099	0.41008198662758594
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.011130084	0.4091623891506394
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.011041609	0.40590988518210663
COHEN SYNDROME	0.011041609	0.40590988518210663
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.011019739	0.4051059036981642
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.011019739	0.4051059036981642
BOHRING-OPITZ SYNDROME	0.010934773	0.40198239703311356
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.010920889	0.40147199561916486
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.010882024	0.4000432466308967
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.010868840000000001	0.3995585785063289
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.3981355276035665
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.010797684	0.39694275287892095
2P15P16.1 MICRODELETION SYNDROME	0.010797684	0.39694275287892095
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.39468836968178844
GAUCHER DISEASE TYPE 3	0.01073636	0.39468836968178844
MERRF	0.01073636	0.39468836968178844
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.010695934	0.3932022354582009
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.010691799	0.3930502252416439
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.010663582999999999	0.3920129531085428
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.010652934	0.3916214762533757
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.010652919	0.3916209248257462
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.010652919	0.3916209248257462
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.010647003	0.3914034417686358
RECURRENT ACUTE PANCREATITIS	0.010642419	0.39123492548503297
MARDEN-WALKER SYNDROME	0.010477694	0.3851793310660835
2Q32Q33 MICRODELETION SYNDROME	0.010477694	0.3851793310660835
1Q44 MICRODELETION SYNDROME	0.010446114000000001	0.38401839209658634
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.010396893	0.3822089374728492
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.010396893	0.3822089374728492
2Q31.1 MICRODELETION SYNDROME	0.010396893	0.3822089374728492
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.010393354	0.3820788373141078
JACOBSEN SYNDROME	0.010338303000000002	0.3800550611516699
RUBINSTEIN-TAYBI SYNDROME	0.010338303000000002	0.3800550611516699
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.010336469999999999	0.3799876766953339
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.010323829999999999	0.37952300701279923
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.010323829999999999	0.37952300701279923
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010298423	0.37858899889379943
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010298423	0.37858899889379943
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010298423	0.37858899889379943
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.010298423	0.37858899889379943
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.010298423	0.37858899889379943
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010298423	0.37858899889379943
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010298423	0.37858899889379943
AICARDI-GOUTIERES SYNDROME 7	0.010298423	0.37858899889379943
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.010298423	0.37858899889379943
MONOSOMY 5P	0.01026572	0.37738677637576695
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010184083	0.37438564988264333
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.010150423	0.373148246281843
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.010118028999999999	0.37195738317298
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.010101	0.3713313657660273
ATYPICAL WERNER SYNDROME	0.010101	0.3713313657660273
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660273
H SYNDROME	0.010101	0.3713313657660273
MANDIBULOACRAL DYSPLASIA	0.010101	0.3713313657660273
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.010101	0.3713313657660273
NEUTRAL LIPID STORAGE MYOPATHY	0.010101	0.3713313657660273
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660273
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010101	0.3713313657660273
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.010101	0.3713313657660273
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.010101	0.3713313657660273
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.010101	0.3713313657660273
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.010101	0.3713313657660273
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.010101	0.3713313657660273
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.010101	0.3713313657660273
APOLIPOPROTEIN C-II DEFICIENCY	0.010101	0.3713313657660273
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.010101	0.3713313657660273
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.010101	0.3713313657660273
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660273
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660273
LYSOSOMAL ACID LIPASE DEFICIENCY	0.010101	0.3713313657660273
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.010101	0.3713313657660273
LCAT DEFICIENCY	0.010101	0.3713313657660273
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.010101	0.3713313657660273
ACQUIRED GENERALIZED LIPODYSTROPHY	0.010101	0.3713313657660273
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.010101	0.3713313657660273
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.010101	0.3713313657660273
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.010101	0.3713313657660273
TANGIER DISEASE	0.010101	0.3713313657660273
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.010101	0.3713313657660273
PROTOPORPHYRIA, ERYTHROPOIETIC	0.010101	0.3713313657660273
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.010101	0.3713313657660273
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.010101	0.3713313657660273
HYPERLIPOPROTEINEMIA, TYPE IV	0.010101	0.3713313657660273
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.010101	0.3713313657660273
ALAGILLE SYNDROME 1; ALGS1	0.010101	0.3713313657660273
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.010101	0.3713313657660273
CHOLESTERYL ESTER STORAGE DISEASE	0.010101	0.3713313657660273
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.010101	0.3713313657660273
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.010101	0.3713313657660273
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.010101	0.3713313657660273
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660273
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.010101	0.3713313657660273
HYPERLIPIDEMIA DUE TO HEPATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.010101	0.3713313657660273
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.010101	0.3713313657660273
GLYCOGEN STORAGE DISEASE IXA	0.010101	0.3713313657660273
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01002304	0.3684654125658373
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.009939814	0.3654058715058191
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009936023	0.3652665073629007
MARDEN-WALKER SYNDROME	0.009935679	0.36525386128926207
NEONATAL MARFAN SYNDROME	0.009932139999999999	0.36512376113052075
6Q16 MICRODELETION SYNDROME	0.009855474000000001	0.36230537775384347
CHROMOSOME 9P DELETION SYNDROME	0.009855474000000001	0.36230537775384347
TOLUENE EMBRYOPATHY	0.009855474000000001	0.36230537775384347
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.009835123	0.3615572375078574
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.009835123	0.3615572375078574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.3604430228395075
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3604430228395075
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3604430228395075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3604430228395075
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3604430228395075
COFFIN-SIRIS SYNDROME 5	0.009792123	0.3599764783030322
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.009760543	0.35881553933353505
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.009760543	0.35881553933353505
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.009760543	0.35881553933353505
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.009757004	0.35868543917479373
RETINITIS PIGMENTOSA 59; RP59	0.009752868999999999	0.35853342895823664
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.009752868999999999	0.35853342895823664
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.009752868999999999	0.35853342895823664
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.009707783	0.35687598455105646
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.009707783	0.35687598455105646
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.009707783	0.35687598455105646
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.009707783	0.35687598455105646
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.009707783	0.35687598455105646
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.009707783	0.35687598455105646
WOLFRAM SYNDROME	0.009638529	0.3543300799470806
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.009606323	0.3531461280645085
HALL-RIGGS SYNDROME	0.009580149	0.3521839236127156
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00957661	0.35205382345397435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009474284	0.348292131212278
PYRUVATE DEHYDROGENASE DEFICIENCY	0.009470963	0.34817004513508676
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.009425929	0.34651451234368913
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.009425929	0.34651451234368913
COG8-CDG	0.009425929	0.34651451234368913
CLASSICAL EHLERS-DANLOS SYNDROME	0.00939426	0.34535030157025637
CONGENITAL HYPOTHYROIDISM	0.009392554000000001	0.345287585867851
NIEMANN-PICK DISEASE, TYPE A	0.009392554000000001	0.345287585867851
GM2-GANGLIOSIDOSIS, AB VARIANT	0.009356213	0.3439516237687219
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00930992	0.3422498078182806
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34038745290394473
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34038745290394473
CARNOSINASE DEFICIENCY	0.00925926	0.34038745290394473
CARNOSINEMIA	0.00925926	0.34038745290394473
GAUCHER DISEASE TYPE 2	0.00925926	0.34038745290394473
PAINE SYNDROME	0.00925926	0.34038745290394473
HYDROXYLYSINURIA	0.00925926	0.34038745290394473
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34038745290394473
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34038745290394473
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34038745290394473
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34038745290394473
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34038745290394473
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34038745290394473
DISTAL TRISOMY 17Q	0.009254242999999999	0.3402030187427678
10Q22.3Q23.3 MICRODELETION SYNDROME	0.009254242999999999	0.3402030187427678
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.009254242999999999	0.3402030187427678
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009250703999999998	0.34007291858402644
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.009241059	0.3397183506182
HENNEKAM-BEEMER SYNDROME	0.009175819	0.33732000804790246
ADRENOMYODYSTROPHY	0.009175819	0.33732000804790246
CONO-SPONDYLAR DYSPLASIA	0.009175819	0.33732000804790246
TRISOMY 13	0.009175819	0.33732000804790246
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.009175819	0.33732000804790246
4Q21 MICRODELETION SYNDROME	0.009175819	0.33732000804790246
DPM1-CDG	0.009175819	0.33732000804790246
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.009169903	0.3371025249907921
8P23.1 MICRODELETION SYNDROME	0.009169903	0.3371025249907921
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.009162229	0.3368204146154937
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.009143022999999998	0.3361143666785664
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.009100022999999999	0.3345336074737413
SARCOSINEMIA	0.009064904	0.3332425683455028
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.009064904	0.3332425683455028
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00906345	0.3331891166272746
LISSENCEPHALY, X-LINKED, 1; LISX1	0.009060769	0.3330905581289458
CRANIOFACIAL DYSSYNOSTOSIS	0.00903873	0.33228036389370996
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.33228036389370996
MUCOLIPIDOSIS TYPE II	0.00903873	0.33228036389370996
TRISOMY XQ28	0.00903873	0.33228036389370996
RING CHROMOSOME 7 SYNDROME	0.00903873	0.33228036389370996
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.009015683	0.3314331137217656
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.008892913	0.32691986238277987
ALLAN-HERNDON-DUDLEY SYNDROME	0.00888451	0.3266109526246834
DISTAL MONOSOMY 19P13.3	0.008849913	0.32533910317795467
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.008849913	0.32533910317795467
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.008847	0.32523201593228823
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.008847	0.32523201593228823
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.008814794	0.3240480640497162
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.008810659	0.32389605383315917
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.008765573	0.32223860942597893
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.008755824	0.3218802182285873
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008708688999999999	0.320147448807205
CHROMOSOME 13Q14 DELETION SYNDROME	0.00867357	0.31885640967896656
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0086344	0.31741644832889676
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008628484	0.3171989652717864
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.008624349	0.31704695505522934
ACROCALLOSAL SYNDROME; ACLS	0.008624349	0.31704695505522934
20Q13.33 MICRODELETION SYNDROME	0.008624349	0.31704695505522934
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00862081	0.316916854896488
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.008532074	0.31365475608720045
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00851935	0.3131869984099401
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00851935	0.3131869984099401
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.3122691655014082
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.3122691655014082
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.3122691655014082
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008494383	0.3122691655014082
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008458923	0.310965590585057
NEURAMINIDASE DEFICIENCY	0.008347359	0.3068642924472171
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.008308494	0.3054355434589489
ARTERIAL TORTUOSITY SYNDROME	0.008308494	0.3054355434589489
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.008308494	0.3054355434589489
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.008308494	0.3054355434589489
DISTAL TRISOMY 15Q	0.008304358999999999	0.3052835332423919
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.008304358999999999	0.3052835332423919
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.008304358999999999	0.3052835332423919
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00826924	0.3039924941141534
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00826924	0.3039924941141534
OROFACIODIGITAL SYNDROME TYPE 6	0.008243973	0.3030636326530297
TRISOMY 17P	0.008224154000000001	0.3023350497069732
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.008224154000000001	0.3023350497069732
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.008220019	0.3021830394904162
RING CHROMOSOME 10 SYNDROME	0.008220019	0.3021830394904162
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.008220019	0.3021830394904162
COFFIN-LOWRY SYNDROME; CLS	0.008220019	0.3021830394904162
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.008220019	0.3021830394904162
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.008167269999999999	0.3002438890881993
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.008167269999999999	0.3002438890881993
GORLIN SYNDROME	0.008167269999999999	0.3002438890881993
FLOATING-HARBOR SYNDROME	0.008165564	0.300181173385794
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008165564	0.300181173385794
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.008161429000000001	0.300029163169237
OCULOCEREBRORENAL SYNDROME OF LOWE	0.008161429000000001	0.300029163169237
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.008161429000000001	0.300029163169237
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.008129223	0.2988452112866648
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008129223	0.2988452112866648
HEART AND BRAIN MALFORMATION SYNDROME	0.008129223	0.2988452112866648
AICARDI-GOUTIÈRES SYNDROME	0.008129223	0.2988452112866648
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.008129223	0.2988452112866648
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.008129223	0.2988452112866648
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.008129223	0.2988452112866648
LISSENCEPHALY 8; LIS8	0.008129223	0.2988452112866648
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.008129223	0.2988452112866648
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.008129223	0.2988452112866648
LISSENCEPHALY 1; LIS1	0.008129223	0.2988452112866648
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.008129223	0.2988452112866648
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.008129223	0.2988452112866648
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008129223	0.2988452112866648
SIFRIM-HITZ-WEISS SYNDROME	0.00808293	0.2971433953362237
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00808293	0.2971433953362237
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00808293	0.2971433953362237
ATAXIA-PANCYTOPENIA SYNDROME	0.00805605	0.2961552370239981
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.008013049999999999	0.29457447781917284
SMITH-LEMLI-OPITZ SYNDROME	0.007993863000000002	0.29386912835724316
COFFIN-SIRIS SYNDROME	0.007993863	0.2938691283572431
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2923656057824025
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.2923656057824025
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.2922135955658455
CROME SYNDROME	0.007948829	0.2922135955658455
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.2922135955658455
1Q41Q42 MICRODELETION SYNDROME	0.007948829	0.2922135955658455
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.2922135955658455
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007948829	0.2922135955658455
LISSENCEPHALY 5; LIS5	0.007948829	0.2922135955658455
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.2922135955658455
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.2922135955658455
SMITH-FINEMAN-MYERS SYNDROME	0.007948829	0.2922135955658455
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.2922135955658455
INTELLECTUAL DISABILITY, WOLFF TYPE	0.007948829	0.2922135955658455
FRYNS SYNDROME	0.007948829	0.2922135955658455
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.2922135955658455
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.007948829	0.2922135955658455
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.007948829	0.2922135955658455
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.2922135955658455
LOWRY-MACLEAN SYNDROME	0.007948829	0.2922135955658455
KEPPEN-LUBINSKY SYNDROME	0.007948829	0.2922135955658455
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.007948829	0.2922135955658455
SECKEL SYNDROME 7; SCKL7	0.007948829	0.2922135955658455
RING CHROMOSOME 22 SYNDROME	0.007846503000000001	0.2884519033241492
FOLATE MALABSORPTION, HEREDITARY	0.007839643	0.28819971708821657
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.007839643	0.28819971708821657
JOUBERT SYNDROME	0.007839643	0.28819971708821657
GALACTOSEMIA	0.007839643	0.28819971708821657
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.007839643	0.28819971708821657
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.007839643	0.28819971708821657
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.007839643	0.28819971708821657
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.007838829	0.2881697929488508
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.007838829	0.2881697929488508
CONGENITAL ADRENAL HYPERPLASIA	0.00783646	0.2880827041452175
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00783646	0.2880827041452175
%608572 BURN-MCKEOWN SYNDROME	0.00783646	0.2880827041452175
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.007762939999999999	0.2853799735233862
FRYNS-SMEETS-THIRY SYNDROME	0.007762939999999999	0.2853799735233862
ARTERIAL TORTUOSITY SYNDROME	0.007762939999999999	0.2853799735233862
MARFAN SYNDROME	0.007762939999999999	0.2853799735233862
SHPRINTZEN-GOLDBERG SYNDROME	0.007762939999999999	0.2853799735233862
CHROMOSOME 10Q26 DELETION SYNDROME	0.0077331629999999995	0.2842853161549657
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0077331629999999995	0.2842853161549657
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0077331629999999995	0.2842853161549657
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.007692282999999999	0.2827824920551226
OPSISMODYSPLASIA	0.0076786	0.2822794797714105
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0076786	0.2822794797714105
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.007665923	0.2818134499007228
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.007665923	0.2818134499007228
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.007665923	0.2818134499007228
GLASS SYNDROME	0.007622922999999999	0.2802326906958976
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.007622922999999999	0.2802326906958976
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.007622922999999999	0.2802326906958976
W SYNDROME	0.007587804	0.27894165156765915
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.007587804	0.27894165156765915
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.007587804	0.27894165156765915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.27894165156765915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.007587804	0.27894165156765915
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.007587804	0.27894165156765915
HYPERMANGANESEMIA WITH DYSTONIA 2	0.007587804	0.27894165156765915
PELGER-HUET ANOMALY; PHA	0.007587804	0.27894165156765915
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.007587804	0.27894165156765915
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.007587804	0.27894165156765915
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007587804	0.27894165156765915
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.27894165156765915
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.27894165156765915
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.007587804	0.27894165156765915
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.27894165156765915
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.27894165156765915
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.007587804	0.27894165156765915
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.27878964135110207
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0075836689999999995	0.27878964135110207
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0075836689999999995	0.27878964135110207
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.27878964135110207
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0075836689999999995	0.27878964135110207
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0075836689999999995	0.27878964135110207
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0075836689999999995	0.27878964135110207
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0075836689999999995	0.27878964135110207
WARBURG MICRO SYNDROME 3; WARBM3	0.0075836689999999995	0.27878964135110207
SALLA DISEASE	0.007578943	0.27861590488593924
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0075789429999999994	0.27861590488593924
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0075789429999999994	0.27861590488593924
WILSON-TURNER SYNDROME	0.007538583	0.27713219694392194
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.007538583	0.27713219694392194
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.007538583	0.27713219694392194
SHUKLA-VERNON SYNDROME; SHUVER	0.007538583	0.27713219694392194
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.007538583	0.27713219694392194
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.007538583	0.27713219694392194
48,XXXY SYNDROME	0.0075167129999999995	0.27632821545997943
49,XXXXY SYNDROME	0.0075167129999999995	0.27632821545997943
ATHYREOSIS	0.007513173999999999	0.2761981153012381
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.007513173999999999	0.2761981153012381
PERMANENT CONGENITAL HYPOTHYROIDISM	0.007513173999999999	0.2761981153012381
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.007509039	0.27604610508468114
CARDIOFACIOCUTANEOUS SYNDROME	0.007452444000000001	0.2739655686382374
CHARGE SYNDROME	0.007452444000000001	0.2739655686382374
OHDO SYNDROME	0.007448309	0.27381355842168037
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.007442173	0.27358798775933596
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007442173	0.27358798775933596
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.007442173	0.27358798775933596
DISTAL MONOSOMY 10P	0.00740741	0.2723100358468397
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2723100358468397
KID SYNDROME	0.00740741	0.2723100358468397
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.2723100358468397
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2723100358468397
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.2723100358468397
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2723100358468397
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2723100358468397
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2723100358468397
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.0073624929999999995	0.2706588041909529
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.0073624929999999995	0.2706588041909529
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00735931	0.2705417912479539
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.007298224	0.2682961573692108
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00729741	0.2682662332298451
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.007294089000000001	0.26814414715265383
MAPLE SYRUP URINE DISEASE; MSUD	0.007294089	0.26814414715265383
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.007294089	0.26814414715265383
FAMILIAL DYSAUTONOMIA	0.007294089	0.26814414715265383
CUTIS LAXA	0.007191744	0.26438175643596007
PEROXISOME BIOGENESIS DISORDER 5B	0.007124504	0.2619098901817171
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.007124504	0.2619098901817171
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.007124504	0.2619098901817171
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.007124504	0.2619098901817171
OPTIC ATROPHY 11; OPA11	0.007124504	0.2619098901817171
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.007124504	0.2619098901817171
JOUBERT SYNDROME 24	0.007124504	0.2619098901817171
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.007124504	0.2619098901817171
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.007124504	0.2619098901817171
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.007124504	0.2619098901817171
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.007120369	0.2617578799651601
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.007120369	0.2617578799651601
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.007081504	0.2603291309768919
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.007081504	0.2603291309768919
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.007081504	0.2603291309768919
16P13.11 MICRODUPLICATION SYNDROME	0.007081504	0.2603291309768919
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.007081504	0.2603291309768919
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.007081504	0.2603291309768919
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.007081504	0.2603291309768919
DISTAL TRISOMY 18Q	0.007081504	0.2603291309768919
HARROD SYNDROME	0.007077369	0.2601771207603349
CLASSIC HOMOCYSTINURIA	0.007077369	0.2601771207603349
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.2588860816320964
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.00704225	0.2588860816320964
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.2588860816320964
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.2588860816320964
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.2588860816320964
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.2588860816320964
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.2588860816320964
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.2588860816320964
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00704225	0.2588860816320964
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.2588860816320964
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.2588860816320964
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.2588860816320964
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00704225	0.2588860816320964
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.2588860816320964
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.2588860816320964
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.2588860816320964
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.2588860816320964
OLIVER SYNDROME	0.00704225	0.2588860816320964
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.2588860816320964
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.2588860816320964
NEURONAL CEROID LIPOFUSCINOSIS	0.007033389	0.2585603349503765
CEREBELLOFACIODENTAL SYNDROME	0.006997164	0.2572286372249162
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.006997164	0.2572286372249162
3Q29 MICRODELETION SYNDROME	0.006997164	0.2572286372249162
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.006997164	0.2572286372249162
GOLDBERG-SHPRINTZEN SYNDROME	0.006997164	0.2572286372249162
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006997164	0.2572286372249162
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.006997164	0.2572286372249162
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006997164	0.2572286372249162
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.006997164	0.2572286372249162
YUNIS-VARON SYNDROME	0.006997164	0.2572286372249162
CLARK-BARAITSER SYNDROME	0.0069930289999999996	0.25707662700835915
AYME-GRIPP SYNDROME; AYGRP	0.0069930289999999996	0.25707662700835915
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0069930289999999996	0.25707662700835915
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0069930289999999996	0.25707662700835915
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0069930289999999996	0.25707662700835915
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0069930289999999996	0.25707662700835915
ATKIN-FLAITZ SYNDROME	0.0069930289999999996	0.25707662700835915
CRONKHITE-CANADA SYNDROME	0.0069930289999999996	0.25707662700835915
C SYNDROME	0.006971158999999999	0.25627264552441664
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00696762	0.25614254536567543
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00696762	0.25614254536567543
CENTRAL CONGENITAL HYPOTHYROIDISM	0.006967619999999999	0.2561425453656754
MOEBIUS SYNDROME	0.006906890000000001	0.2539099987026746
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.006906890000000001	0.2539099987026746
DUBOWITZ SYNDROME	0.006906890000000001	0.2539099987026746
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.006900754	0.25368442804033026
PRADER-WILLI-LIKE SYNDROME	0.006827603	0.2509952625381868
NEPHROGENIC DIABETES INSIPIDUS	0.006827603	0.2509952625381868
DESANTO-SHINAWI SYNDROME	0.006827603	0.2509952625381868
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006827603	0.2509952625381868
CHROMOSOME 19P13.13 DELETION SYNDROME	0.006827603	0.2509952625381868
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006827603	0.2509952625381868
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.006827603	0.2509952625381868
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006827603	0.2509952625381868
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006827603	0.2509952625381868
ALEXANDER DISEASE	0.006816939	0.2506032342553902
2Q23.1 MICRODELETION SYNDROME	0.006816939	0.2506032342553902
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.006766873000000001	0.2487627158751861
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.006766873000000001	0.2487627158751861
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.006766873000000001	0.2487627158751861
ARGININOSUCCINIC ACIDURIA	0.006612653	0.24309330460615958
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.006612653	0.24309330460615958
BOUCHER-NEUHAUSER SYNDROME	0.00660531	0.2428233624005542
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00657895	0.24185432024615436
BEHR SYNDROME	0.00657895	0.24185432024615436
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00657895	0.24185432024615436
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00657895	0.24185432024615436
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00657895	0.24185432024615436
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00657895	0.24185432024615436
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00657895	0.24185432024615436
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00657895	0.24185432024615436
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00657895	0.24185432024615436
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00657895	0.24185432024615436
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00653595	0.24027356104132916
LOEYS-DIETZ SYNDROME 3; LDS3	0.00653595	0.24027356104132916
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00653595	0.24027356104132916
PROLIDASE DEFICIENCY	0.00653595	0.24027356104132916
HAIM-MUNK SYNDROME	0.00653595	0.24027356104132916
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00653595	0.24027356104132916
MOSAIC TRISOMY 1	0.00653595	0.24027356104132916
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.00653595	0.24027356104132916
NON-DISTAL TRISOMY 13Q	0.00653595	0.24027356104132916
LOEYS-DIETZ SYNDROME	0.00653595	0.24027356104132916
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00653595	0.24027356104132916
MARFANOID HYPERMOBILITY SYNDROME	0.00653595	0.24027356104132916
MARFAN SYNDROME; MFS	0.00653595	0.24027356104132916
FRONTOMETAPHYSEAL DYSPLASIA	0.00653595	0.24027356104132916
ACHARD SYNDROME	0.00653595	0.24027356104132916
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00653595	0.24027356104132916
3Q27.3 MICRODELETION SYNDROME	0.00653595	0.24027356104132916
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.00653595	0.24027356104132916
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.00653595	0.24027356104132916
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00653595	0.24027356104132916
MARFANOID HABITUS WITH SITUS INVERSUS	0.00653595	0.24027356104132916
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00653595	0.24027356104132916
FAMILIAL VISCERAL MYOPATHY	0.00653595	0.24027356104132916
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00653595	0.24027356104132916
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00653595	0.24027356104132916
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.00653595	0.24027356104132916
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00653595	0.24027356104132916
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00653595	0.24027356104132916
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00653595	0.24027356104132916
LOEYS-DIETZ SYNDROME 5	0.00653595	0.24027356104132916
CUTIS LAXA-MARFANOID SYNDROME	0.00653595	0.24027356104132916
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00653595	0.24027356104132916
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00653595	0.24027356104132916
PAPILLON-LEFÈVRE SYNDROME	0.00653595	0.24027356104132916
NAKAJO-NISHIMURA SYNDROME	0.00653595	0.24027356104132916
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00653595	0.24027356104132916
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00653595	0.24027356104132916
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00653595	0.24027356104132916
TRISOMY 1Q	0.00653595	0.24027356104132916
ANTLEY-BIXLER SYNDROME	0.00653595	0.24027356104132916
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00653595	0.24027356104132916
STICKLER SYNDROME, TYPE I	0.00653595	0.24027356104132916
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00653595	0.24027356104132916
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00653595	0.24027356104132916
BRITTLE CORNEA SYNDROME	0.00653595	0.24027356104132916
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00653595	0.24027356104132916
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00653595	0.24027356104132916
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.00653595	0.24027356104132916
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00653595	0.24027356104132916
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00653595	0.24027356104132916
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00653595	0.24027356104132916
601095 HARROD SYNDROME	0.00653595	0.24027356104132916
REFSUM DISEASE	0.00649197	0.2386567752313708
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00645161	0.23717306728935345
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00645161	0.23717306728935345
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00645161	0.23717306728935345
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00645161	0.23717306728935345
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00645161	0.23717306728935345
SAY SYNDROME	0.00645161	0.23717306728935345
ACROCRANIOFACIAL DYSOSTOSIS	0.00645161	0.23717306728935345
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00645161	0.23717306728935345
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00645161	0.23717306728935345
HURIEZ SYNDROME; HRZ	0.00645161	0.23717306728935345
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.00645161	0.23717306728935345
ACROMEGALY	0.00645161	0.23717306728935345
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00645161	0.23717306728935345
SOMATOMAMMOTROPINOMA	0.00645161	0.23717306728935345
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00645161	0.23717306728935345
ERYTHROKERATODERMIA VARIABILIS	0.00645161	0.23717306728935345
BASAN SYNDROME	0.00645161	0.23717306728935345
PARANA HARD SKIN SYNDROME	0.00645161	0.23717306728935345
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00645161	0.23717306728935345
SATOYOSHI SYNDROME	0.00645161	0.23717306728935345
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00645161	0.23717306728935345
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.00645161	0.23717306728935345
CLEIDOCRANIAL DYSPLASIA	0.00645161	0.23717306728935345
OTOFACIOCERVICAL SYNDROME 2	0.00645161	0.23717306728935345
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006364593	0.2339741620864169
CANAVAN DISEASE	0.006362543000000001	0.2338988003103729
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.006362543000000001	0.2338988003103729
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.006362543000000001	0.2338988003103729
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.006362543000000001	0.2338988003103729
COFFIN-SIRIS SYNDROME 1; CSS1	0.006362543000000001	0.2338988003103729
VICI SYNDROME	0.006362543	0.23389880031037288
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.006362543	0.23389880031037288
KABUKI SYNDROME 1	0.006362543	0.23389880031037288
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.006362543	0.23389880031037288
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.006362543	0.23389880031037288
CHROMOSOME 16P13.3 DELETION SYNDROME	0.006362543	0.23389880031037288
SOTOS SYNDROME	0.006362543	0.23389880031037288
METHYLMALONIC ACIDURIA, CBLA TYPE	0.006362543	0.23389880031037288
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0062897230000000005	0.23122180297792247
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0062897230000000005	0.23122180297792247
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006286184	0.23109170281918112
COFFIN-SIRIS SYNDROME 7; CSS7	0.006286184	0.23109170281918112
AU-KLINE SYNDROME; AUKS	0.006286184	0.23109170281918112
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006286184	0.23109170281918112
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.006286184	0.23109170281918112
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.006286183999999999	0.2310917028191811
PERIPHERAL HYPOTHYROIDISM	0.006286183999999999	0.2310917028191811
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006282049	0.2309396926026241
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006282049	0.2309396926026241
JOUBERT SYNDROME 10	0.006225454	0.22885915615618035
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.006221319000000001	0.22870714593962335
PETTIGREW SYNDROME	0.006215183	0.22848157527727897
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.006215183	0.22848157527727897
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.006135503	0.2255523917088959
MONOSOMY 9Q22.3	0.006114483	0.22477965779063025
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.006114483	0.22477965779063025
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.006071234	0.22318974488715385
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.006067099000000001	0.22303773467059687
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.005960262999999999	0.21911024652160366
RFT1-CDG	0.005960262999999999	0.21911024652160366
JOUBERT SYNDROME WITH OCULAR DEFECT	0.005960262999999999	0.21911024652160366
JOUBERT SYNDROME WITH RENAL DEFECT	0.005960262999999999	0.21911024652160366
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00595708	0.21899323357860467
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005885393	0.21635788741310927
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.005885393	0.21635788741310927
HOLOPROSENCEPHALY 2; HPE2	0.005885393	0.21635788741310927
KLEEFSTRA SYNDROME	0.005885393	0.21635788741310927
BAKER-GORDON SYNDROME; BAGOS	0.005823173999999999	0.21407060236741113
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0058211240000000004	0.2139952405913672
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.0058211240000000004	0.2139952405913672
3C SYNDROME	0.0058211240000000004	0.2139952405913672
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0058211240000000004	0.2139952405913672
HYPOTONIA-CYSTINURIA SYNDROME	0.0058211240000000004	0.2139952405913672
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.005816989000000001	0.21384323037481018
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.005816989000000001	0.21384323037481018
HYPOPHOSPHATASIA	0.005816989000000001	0.21384323037481018
CORNELIA DE LANGE SYNDROME	0.005816989000000001	0.21384323037481018
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.005816989	0.21384323037481012
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.005816989	0.21384323037481012
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.005816989	0.21384323037481012
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.005816989	0.21384323037481012
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.005816989	0.21384323037481012
ACROCARDIOFACIAL SYNDROME	0.005816989	0.21384323037481012
MENKES DISEASE	0.005816989	0.21384323037481012
REVESZ SYNDROME	0.005810533999999999	0.21360593268487646
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.005748303999999999	0.2113182432589167
COFFIN-SIRIS SYNDROME 6; CSS6	0.005748303999999999	0.2113182432589167
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.2110361328836184
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00574063	0.2110361328836184
SILVER-RUSSELL SYNDROME	0.00574063	0.2110361328836184
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.2110361328836184
CRI-DU-CHAT SYNDROME	0.0056799	0.2088035862206176
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0056799	0.2088035862206176
GMS SYNDROME	0.0056799	0.2088035862206176
MARTSOLF SYNDROME	0.0056799	0.2088035862206176
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005673764	0.20857801555827327
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.20857801555827327
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.005669629000000001	0.20842600534171624
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.20842600534171624
ATYPICAL JUVENILE PARKINSONISM	0.005669629000000001	0.20842600534171624
HUNTINGTON DISEASE; HD	0.005669629000000001	0.20842600534171624
RAPID-ONSET DYSTONIA-PARKINSONISM	0.005669629000000001	0.20842600534171624
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.005669629000000001	0.20842600534171624
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.005594083999999999	0.2056488319898902
GITELMAN SYNDROME	0.005589949	0.20549682177333323
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005589949	0.20549682177333323
16P11.2P12.2 MICRODELETION SYNDROME	0.005573063999999999	0.2048760980716245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.005573063999999999	0.2048760980716245
14Q12 MICRODELETION SYNDROME	0.005568929	0.2047240878550675
PALLISTER-KILLIAN SYNDROME	0.005568929	0.2047240878550675
LARSEN-LIKE SYNDROME	0.005560424	0.20441142838908982
ASPARTYLGLUCOSAMINURIA; AGU	0.005556289	0.20425941817253285
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005556289	0.20425941817253285
XYLOSIDASE DEFICIENCY	0.005556289	0.20425941817253285
CAMURATI-ENGELMANN DISEASE	0.00552568	0.2031341749515911
15Q11Q13 MICRODUPLICATION SYNDROME	0.005422382999999999	0.19933678696133927
ISOLATED COMPLEX I DEFICIENCY	0.005418843999999999	0.19920668680259798
CHOREOACANTHOCYTOSIS	0.005414709	0.199054676586041
CITRULLINEMIA TYPE I	0.005414709	0.199054676586041
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005343974	0.19645432769410354
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005343974	0.19645432769410354
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.005343974	0.19645432769410354
FAMILIAL THYROID DYSHORMONOGENESIS	0.005343974	0.19645432769410354
THYROID HEMIAGENESIS	0.005343974	0.19645432769410354
THYROID ECTOPIA	0.005343974	0.19645432769410354
THYROID HYPOPLASIA	0.005343974	0.19645432769410354
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.005343974	0.19645432769410354
LYNCH SYNDROME	0.005339839	0.19630231747754653
FAMILIAL COLORECTAL CANCER TYPE X	0.005339839	0.19630231747754653
HYPOPHOSPHATASIA, INFANTILE	0.005339839	0.19630231747754653
ACUTE ADRENAL INSUFFICIENCY	0.005339839	0.19630231747754653
GOLDENHAR SYNDROME	0.00527557	0.19393967065580445
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00527557	0.19393967065580445
MYOTONIC DYSTROPHY 1	0.00527557	0.19393967065580445
STÜVE-WIEDEMANN SYNDROME	0.00527557	0.19393967065580445
ESOPHAGEAL ATRESIA	0.00527557	0.19393967065580445
NOONAN SYNDROME	0.00527557	0.19393967065580445
NEMALINE MYOPATHY 4	0.00527557	0.19393967065580445
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00527557	0.19393967065580445
PRADER-WILLI SYNDROME (TYPE 2)	0.00527557	0.19393967065580445
PRADER-WILLI SYNDROME (TYPE 1)	0.00527557	0.19393967065580445
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.19355036274931375
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.19355036274931375
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.19355036274931375
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.19355036274931375
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00520275	0.19126267332335398
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.005135553000000001	0.18879238782831592
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.005135553000000001	0.18879238782831592
CORNELIA DE LANGE SYNDROME 3	0.005135553000000001	0.18879238782831592
POTOCKI-LUPSKI SYNDROME	0.005135553000000001	0.18879238782831592
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.005135553000000001	0.18879238782831592
SHASHI-PENA SYNDROME; SHAPNS	0.005135553000000001	0.18879238782831592
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.005135553000000001	0.18879238782831592
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.005135553000000001	0.18879238782831592
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.005135553000000001	0.18879238782831592
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.005135553000000001	0.18879238782831592
PETERS-PLUS SYNDROME; PTRPLS	0.005135553000000001	0.18879238782831592
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00512821	0.1885224456227105
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.1885224456227105
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00512821	0.1885224456227105
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.1885224456227105
CHIARI MALFORMATION TYPE I	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.1885224456227105
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.1885224456227105
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00512821	0.1885224456227105
SYRINGOMYELIA, ISOLATED	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.1885224456227105
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00512821	0.1885224456227105
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.1885224456227105
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.1885224456227105
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.1885224456227105
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00512821	0.1885224456227105
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.1885224456227105
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 38	0.00512821	0.1885224456227105
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00512821	0.1885224456227105
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.1885224456227105
SUSAC SYNDROME	0.00512821	0.1885224456227105
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.1885224456227105
TYPHOID	0.00504853	0.18559326205432747
TURCOT SYNDROME WITH POLYPOSIS	0.00504853	0.18559326205432747
NEUROFERRITINOPATHY	0.00504853	0.18559326205432747
TORIELLO-LACASSIE-DROSTE SYNDROME	0.005027509999999999	0.18482052813606173
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.005027509999999999	0.18482052813606173
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00501487	0.18435585845352712
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00501487	0.18435585845352712
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00501487	0.18435585845352712
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004887493	0.1796732453085732
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004887493	0.1796732453085732
8P11.2 DELETION SYNDROME	0.004887493	0.1796732453085732
PHELAN-MCDERMID SYNDROME	0.004887493	0.1796732453085732
MONOSOMY 22Q13.3	0.004887493	0.1796732453085732
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.004887493	0.1796732453085732
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004887493	0.1796732453085732
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004887493	0.1796732453085732
TETRASOMY 9P	0.004887493	0.1796732453085732
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004887493	0.1796732453085732
11Q22.2Q22.3 MICRODELETION SYNDROME	0.004887493	0.1796732453085732
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004887493	0.1796732453085732
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004887493	0.1796732453085732
JOUBERT SYNDROME 1	0.004880964	0.1794332272423336
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.004876829	0.17928121702577657
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.17920857562603856
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004874853	0.17920857562603856
CHIARI MALFORMATION TYPE II	0.00487329	0.17915111686703525
JUVENILE DERMATOMYOSITIS	0.00479842	0.1763987577585408
INFANT BOTULISM	0.00479842	0.1763987577585408
POLYMYOSITIS	0.00479842	0.1763987577585408
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004733273	0.1740038340395467
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004733273	0.1740038340395467
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004733273	0.1740038340395467
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004733273	0.1740038340395467
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004733273	0.1740038340395467
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.004733273	0.1740038340395467
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.004733273	0.1740038340395467
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004733273	0.1740038340395467
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004733273	0.1740038340395467
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004733273	0.1740038340395467
FG SYNDROME TYPE 1	0.004658403	0.17125147493105228
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004658403	0.17125147493105228
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004658403	0.17125147493105228
611961 STEVENSON-CAREY SYNDROME	0.004658403	0.17125147493105228
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004658403	0.17125147493105228
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004658403	0.17125147493105228
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004658403	0.17125147493105228
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004658403	0.17125147493105228
PETERS PLUS SYNDROME	0.004594134000000001	0.1688888281093102
OCULOFACIOCARDIODENTAL SYNDROME	0.004594134000000001	0.1688888281093102
WEAVER SYNDROME	0.004594134000000001	0.1688888281093102
SCLERODERMA	0.004589999000000001	0.16873681789275316
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004589999000000001	0.16873681789275316
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.004589999000000001	0.16873681789275316
2Q33.1 DELETION SYNDROME	0.004589999000000001	0.16873681789275316
HYPOADRENOCORTICISM, FAMILIAL	0.004589999000000001	0.16873681789275316
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.004589999000000001	0.16873681789275316
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.004589999000000001	0.16873681789275316
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.004589999000000001	0.16873681789275316
SYSTEMIC SCLEROSIS	0.004589999000000001	0.16873681789275316
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.004483163	0.16480932974376006
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.004483163	0.16480932974376006
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004483163	0.16480932974376006
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.004483163	0.16480932974376006
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004483163	0.16480932974376006
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.004483163	0.16480932974376006
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004483163	0.16480932974376006
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004483162999999999	0.16480932974376
48,XYYY SYNDROME	0.004346074	0.1597696855895675
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004346074	0.1597696855895675
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004346074	0.1597696855895675
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004346074	0.1597696855895675
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004346074	0.1597696855895675
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004346074	0.1597696855895675
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004346074	0.1597696855895675
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.004346074	0.1597696855895675
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.004346073999999999	0.15976968558956747
DUPLICATION/INVERSION 15Q11	0.0043419389999999995	0.15961767537301044
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0043419389999999995	0.15961767537301044
JOUBERT SYNDROME 3; JBTS3	0.00433541	0.15937765730677084
NON-DISTAL MONOSOMY 10Q	0.00433541	0.15937765730677084
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.15930501590703283
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.15930501590703283
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.1591530056904758
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.1591530056904758
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.1591530056904758
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.1591530056904758
GAPO SYNDROME; GAPOS	0.004329299	0.1591530056904758
EPILEPSY-TELANGIECTASIA	0.004329299	0.1591530056904758
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0041953929999999995	0.15423037447928228
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0041953929999999995	0.15423037447928228
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004191853999999999	0.15410027432054096
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004191853999999999	0.15410027432054096
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004191853999999999	0.15410027432054096
COCKAYNE SYNDROME	0.0041877189999999995	0.15394826410398396
PROPIONIC ACIDEMIA	0.004116984	0.15134791521204655
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.004116984	0.15134791521204655
ADIPOSIS DOLOROSA	0.004112849	0.15119590499548952
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15119590499548952
KAPUR-TORIELLO SYNDROME	0.004112849	0.15119590499548952
ADDISON DISEASE	0.004112849	0.15119590499548952
HEREDITARY COPROPORPHYRIA	0.004112849	0.15119590499548952
PORPHYRIA VARIEGATA	0.004112849	0.15119590499548952
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15119590499548952
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004112849	0.15119590499548952
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15119590499548952
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15119590499548952
PORPHYRIA	0.004112849	0.15119590499548952
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15119590499548952
MOWAT-WILSON SYNDROME; MOWS	0.004112849	0.15119590499548952
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15119590499548952
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15119590499548952
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15119590499548952
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.14883325817374743
CAFFEY DISEASE	0.00404858	0.14883325817374743
RING CHROMOSOME 1 SYNDROME	0.00404858	0.14883325817374743
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.14883325817374743
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00404858	0.14883325817374743
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00404858	0.14883325817374743
FREEMAN-SHELDON SYNDROME	0.00404858	0.14883325817374743
AORTIC ARCH DEFECTS	0.00404858	0.14883325817374743
CHERUBISM	0.00404858	0.14883325817374743
INCLUSION BODY MYOSITIS	0.00404858	0.14883325817374743
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.14883325817374743
APERT SYNDROME	0.00404858	0.14883325817374743
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.14883325817374743
PEMPHIGUS VULGARIS	0.00404858	0.14883325817374743
JEUNE SYNDROME	0.00404858	0.14883325817374743
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.14883325817374743
SCHWARTZ-JAMPEL SYNDROME	0.00404858	0.14883325817374743
LEPRECHAUNISM	0.00404858	0.14883325817374743
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00404858	0.14883325817374743
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.14883325817374743
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.14883325817374743
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.14883325817374743
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.14883325817374743
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.14883325817374743
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.14883325817374743
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.14883325817374743
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.14883325817374743
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.14883325817374743
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00404858	0.14883325817374743
PIERRE ROBIN SYNDROME	0.00404858	0.14883325817374743
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00404858	0.14883325817374743
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.14883325817374743
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.14883325817374743
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.14883325817374743
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.003945283	0.14503587018349565
INFANTILE SIALIC ACID STORAGE DISEASE	0.003945283	0.14503587018349565
LATHOSTEROLOSIS	0.003945283	0.14503587018349565
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003945283	0.14503587018349565
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.003945283	0.14503587018349565
22Q11.2 MICRODUPLICATION SYNDROME	0.003945283	0.14503587018349565
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.003945283	0.14503587018349565
20P12.3 MICRODELETION SYNDROME	0.003945283	0.14503587018349565
1Q21.1 MICRODELETION SYNDROME	0.003945283	0.14503587018349565
MONOSOMY 9P	0.003945283	0.14503587018349565
C SYNDROME	0.003945283	0.14503587018349565
WEAVER SYNDROME	0.003945283	0.14503587018349565
SIMPSON-GOLABI-BEHMEL SYNDROME	0.003945283	0.14503587018349565
TRISOMY X	0.003945283	0.14503587018349565
TEMPLE-BARAITSER SYNDROME; TMBTS	0.003945283	0.14503587018349565
PRIMARY CONGENITAL HYPOTHYROIDISM	0.003941744	0.14490577002475433
HURLER SYNDROME	0.003941744	0.14490577002475433
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003941744	0.14490577002475433
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003941744	0.14490577002475433
GALACTOSE EPIMERASE DEFICIENCY	0.003941744	0.14490577002475433
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.003937609	0.1447537598081973
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.003937609	0.1447537598081973
KABUKI SYNDROME	0.003937609	0.1447537598081973
5Q14.3 MICRODELETION SYNDROME	0.003937609	0.1447537598081973
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.003937609	0.1447537598081973
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.003937609	0.1447537598081973
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.003937609	0.1447537598081973
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.003937609	0.1447537598081973
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0038005199999999995	0.13971411565400474
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0038005199999999995	0.13971411565400474
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0038005199999999995	0.13971411565400474
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0038005199999999995	0.13971411565400474
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.003791063	0.13936645891446914
ELEJALDE DISEASE	0.003791063	0.13936645891446914
MAPLE SYRUP URINE DISEASE	0.003791063	0.13936645891446914
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.003791063	0.13936645891446914
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.003791063	0.13936645891446914
MEVALONIC ACIDURIA	0.003791063	0.13936645891446914
INFANTILE REFSUM DISEASE	0.0037910629999999995	0.1393664589144691
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0037910629999999995	0.1393664589144691
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0037910629999999995	0.1393664589144691
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0037910629999999995	0.1393664589144691
HARTNUP DISEASE	0.0037910629999999995	0.1393664589144691
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0037910629999999995	0.1393664589144691
COACH SYNDROME	0.0037910629999999995	0.1393664589144691
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0037910629999999995	0.1393664589144691
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0037910629999999995	0.1393664589144691
TAY-SACHS DISEASE	0.0037910629999999995	0.1393664589144691
LEIGH SYNDROME; LS	0.0037910629999999995	0.1393664589144691
PELIZAEUS-MERZBACHER DISEASE	0.0037910629999999995	0.1393664589144691
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.1392494459714701
ALKAPTONURIA	0.00378788	0.1392494459714701
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.1392494459714701
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.1392494459714701
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.1392494459714701
XANTHINURIA, TYPE I	0.00378788	0.1392494459714701
ZINC, ELEVATED PLASMA	0.00378788	0.1392494459714701
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.1392494459714701
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.1392494459714701
DERMATOLEUKODYSTROPHY	0.00378788	0.1392494459714701
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.1392494459714701
OSTEOMESOPYKNOSIS	0.00378788	0.1392494459714701
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.1392494459714701
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.1392494459714701
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.1392494459714701
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.1392494459714701
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.1392494459714701
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.1392494459714701
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.1392494459714701
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.1392494459714701
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.1392494459714701
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.1392494459714701
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.1392494459714701
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.1392494459714701
TRISOMY 18-LIKE SYNDROME	0.00378788	0.1392494459714701
FINGERPRINT BODY MYOPATHY	0.00378788	0.1392494459714701
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.1392494459714701
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.1392494459714701
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.1392494459714701
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.1392494459714701
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.1392494459714701
CEPHALIN LIPIDOSIS	0.00378788	0.1392494459714701
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.1392494459714701
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.1392494459714701
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.1392494459714701
AREDYLD	0.00378788	0.1392494459714701
CITRULLINE TRANSPORT DEFECT	0.00378788	0.1392494459714701
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.1392494459714701
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.1392494459714701
PENDRED SYNDROME	0.00378788	0.1392494459714701
DERMATITIS, ATOPIC	0.00378788	0.1392494459714701
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.1392494459714701
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.1392494459714701
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.1392494459714701
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.1392494459714701
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.1392494459714701
T-SUBSTANCE ANOMALY	0.00378788	0.1392494459714701
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.1392494459714701
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.1392494459714701
OSTEOGENIC SARCOMA	0.00378788	0.1392494459714701
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.1392494459714701
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.1392494459714701
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.1392494459714701
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.1392494459714701
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.1392494459714701
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.1392494459714701
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.1392494459714701
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.1392494459714701
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.1392494459714701
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.1392494459714701
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.1392494459714701
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.1392494459714701
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.1392494459714701
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.1392494459714701
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.1392494459714701
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.1392494459714701
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.1392494459714701
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.1392494459714701
PREMATURE OVARIAN FAILURE 1	0.00378788	0.1392494459714701
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.1392494459714701
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.1392494459714701
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.1392494459714701
PYGMY	0.00378788	0.1392494459714701
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.1392494459714701
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.1392494459714701
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.1392494459714701
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.1392494459714701
PROGESTERONE RESISTANCE	0.00378788	0.1392494459714701
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.1392494459714701
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.1392494459714701
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.1392494459714701
PITUITARY DWARFISM IV	0.00378788	0.1392494459714701
LARON SYNDROME	0.00378788	0.1392494459714701
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.1392494459714701
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.1392494459714701
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.1392494459714701
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.1392494459714701
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.1392494459714701
ONCOCYTOMA	0.00378788	0.1392494459714701
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.1392494459714701
GLUTATHIONURIA	0.00378788	0.1392494459714701
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.1392494459714701
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.1392494459714701
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.1392494459714701
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.1392494459714701
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.1392494459714701
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.1392494459714701
BARTTER SYNDROME	0.00378788	0.1392494459714701
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.1392494459714701
SCHIZOPHRENIA 4	0.00378788	0.1392494459714701
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.1392494459714701
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.1392494459714701
ETHANOLAMINOSIS	0.00378788	0.1392494459714701
HOOFT DISEASE	0.00378788	0.1392494459714701
HYPOASCORBEMIA	0.00378788	0.1392494459714701
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.1392494459714701
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.1392494459714701
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.1392494459714701
XM SYSTEM	0.00378788	0.1392494459714701
DELETED IN AZOOSPERMIA	0.00378788	0.1392494459714701
GONADOBLASTOMA	0.00378788	0.1392494459714701
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.1392494459714701
LYMPHOKINE DEFICIENCY	0.00378788	0.1392494459714701
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.1392494459714701
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.1392494459714701
LIPASE DEFICIENCY, COMBINED	0.00378788	0.1392494459714701
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.1392494459714701
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.1392494459714701
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.1392494459714701
ACETYLATION, SLOW	0.00378788	0.1392494459714701
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.1392494459714701
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.1392494459714701
MACROCYTOSIS, FAMILIAL	0.00378788	0.1392494459714701
ICHTHYOSIS, X-LINKED	0.00378788	0.1392494459714701
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.1392494459714701
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.1392494459714701
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.1392494459714701
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.1392494459714701
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.1392494459714701
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.1392494459714701
FLOOD FACTOR DEFICIENCY	0.00378788	0.1392494459714701
PERRY SYNDROME	0.00378788	0.1392494459714701
MACULAR CORNEAL DYSTROPHY	0.00378788	0.1392494459714701
BEETURIA	0.00378788	0.1392494459714701
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.1392494459714701
MYOPATHY, SPHEROID BODY	0.00378788	0.1392494459714701
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.1392494459714701
CARBOXYLESTERASE 1	0.00378788	0.1392494459714701
HEINZ BODY ANEMIAS	0.00378788	0.1392494459714701
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.1392494459714701
PACMAN DYSPLASIA	0.00378788	0.1392494459714701
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.1392494459714701
PARAOXONASE 1	0.00378788	0.1392494459714701
COUMARIN RESISTANCE	0.00378788	0.1392494459714701
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.1392494459714701
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.1392494459714701
GLUTATHIONE REDUCTASE	0.00378788	0.1392494459714701
GLOMUVENOUS MALFORMATIONS	0.00378788	0.1392494459714701
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.1392494459714701
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.1392494459714701
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.1392494459714701
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.1392494459714701
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.1392494459714701
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.1392494459714701
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.1392494459714701
CALVARIAL HYPEROSTOSIS	0.00378788	0.1392494459714701
OVARIAN CANCER	0.00378788	0.1392494459714701
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.1392494459714701
ALAND ISLAND EYE DISEASE	0.00378788	0.1392494459714701
APOLIPOPROTEIN(A)	0.00378788	0.1392494459714701
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.1392494459714701
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.1392494459714701
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.1392494459714701
HYPERPROGLUCAGONEMIA	0.00378788	0.1392494459714701
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.1392494459714701
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.1392494459714701
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.1392494459714701
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.1392494459714701
JOUBERT SYNDROME 14	0.0036539739999999995	0.13432681476027655
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0036539739999999995	0.13432681476027655
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0036498389999999998	0.13417480454371955
MILLER-DIEKER SYNDROME	0.0036498389999999998	0.13417480454371955
OROFACIODIGITAL SYNDROME TYPE 1	0.0036498389999999998	0.13417480454371955
CLASSIC GALACTOSEMIA	0.0036462999999999995	0.13404470438497823
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0036462999999999995	0.13404470438497823
PANHYPOPITUITARISM	0.00357143	0.1312923452764838
RHEUMATIC FEVER	0.00357143	0.1312923452764838
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.1312923452764838
WOUND BOTULISM	0.00357143	0.1312923452764838
NK-CELL ENTEROPATHY	0.00357143	0.1312923452764838
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.1312923452764838
OCHOA SYNDROME	0.00357143	0.1312923452764838
VISCERAL MYOPATHY; VSCM	0.00357143	0.1312923452764838
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.1312923452764838
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.1312923452764838
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.1312923452764838
GRFOMA	0.00357143	0.1312923452764838
PPOMA	0.00357143	0.1312923452764838
INHALATIONAL BOTULISM	0.00357143	0.1312923452764838
PRUNE BELLY SYNDROME	0.00357143	0.1312923452764838
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.1312923452764838
SOMATOSTATINOMA	0.00357143	0.1312923452764838
GLUCAGONOMA	0.00357143	0.1312923452764838
SHEEHAN SYNDROME	0.00357143	0.1312923452764838
IATROGENIC BOTULISM	0.00357143	0.1312923452764838
PUDENDAL NEURALGIA	0.00357143	0.1312923452764838
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.1312923452764838
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.1312923452764838
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.1312923452764838
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.1312923452764838
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.1312923452764838
MALT LYMPHOMA	0.00357143	0.1312923452764838
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00357143	0.1312923452764838
UROFACIAL SYNDROME	0.00357143	0.1312923452764838
KAPUR-TORIELLO SYNDROME	0.00357143	0.1312923452764838
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.1312923452764838
BOTULISM	0.00357143	0.1312923452764838
PSEUDOMYXOMA PERITONEI	0.00357143	0.1312923452764838
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.1312923452764838
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.1312923452764838
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.1312923452764838
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.1312923452764838
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.1312923452764838
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.1312923452764838
LIDDLE SYNDROME	0.00357143	0.1312923452764838
FOODBORNE BOTULISM	0.00357143	0.1312923452764838
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.1312923452764838
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.1312923452764838
MYXEDEMA	0.00357143	0.1312923452764838
WAARDENBURG-SHAH SYNDROME	0.00357143	0.1312923452764838
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.1312923452764838
UROFACIAL SYNDROME 2	0.00357143	0.1312923452764838
ADIPOSIS DOLOROSA	0.00357143	0.1312923452764838
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.1312923452764838
HINMAN SYNDROME	0.00357143	0.1312923452764838
FG SYNDROME 2; FGS2	0.00357143	0.1312923452764838
CAP POLYPOSIS	0.00357143	0.1312923452764838
TOWNES-BROCKS SYNDROME	0.00357143	0.1312923452764838
ATTRV30M AMYLOIDOSIS	0.00357143	0.1312923452764838
PURE AUTONOMIC FAILURE	0.00357143	0.1312923452764838
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.1312923452764838
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.1312923452764838
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00357143	0.1312923452764838
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.1312923452764838
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.1312923452764838
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.1312923452764838
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.1312923452764838
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.1312923452764838
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.1312923452764838
PARATHYROID CARCINOMA	0.00357143	0.1312923452764838
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.1312923452764838
HIRSCHSPRUNG DISEASE	0.00357143	0.1312923452764838
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.1312923452764838
PORPHYRIA VARIEGATA	0.00357143	0.1312923452764838
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.1312923452764838
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.1312923452764838
14Q22Q23 MICRODELETION SYNDROME	0.003403864	0.12513231046448992
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.003403864	0.12513231046448992
MONOSOMY 18P	0.003403864	0.12513231046448992
17Q21.31 MICRODUPLICATION SYNDROME	0.003403864	0.12513231046448992
CODAS SYNDROME	0.003403864	0.12513231046448992
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.003403864	0.12513231046448992
LATERAL MENINGOCELE SYNDROME	0.003403864	0.12513231046448992
HADZISELIMOVIC SYNDROME	0.003403864	0.12513231046448992
DISTAL MONOSOMY 9P	0.003403864	0.12513231046448992
TRISOMY 18	0.003403864	0.12513231046448992
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.003403864	0.12513231046448992
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.003403864	0.12513231046448992
OROFACIODIGITAL SYNDROME VI	0.003403864	0.12513231046448992
8Q12 MICRODUPLICATION SYNDROME	0.0034038639999999995	0.12513231046448992
TETRASOMY X	0.0034038639999999995	0.12513231046448992
DISTAL MONOSOMY 3P	0.0033997289999999998	0.12498030024793289
CHROMOSOME 18Q DELETION SYNDROME	0.0033997289999999998	0.12498030024793289
WOLCOTT-RALLISON SYNDROME	0.0033997289999999998	0.12498030024793289
ZUNICH NEUROECTODERMAL SYNDROME	0.0033997289999999998	0.12498030024793289
POTOCKI-SHAFFER SYNDROME	0.0033997289999999998	0.12498030024793289
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.0033997289999999998	0.12498030024793289
INFANTILE SYSTEMIC HYALINOSIS	0.0033961899999999995	0.12485020008919158
NATIVE AMERICAN MYOPATHY	0.0033961899999999995	0.12485020008919158
STUVE-WIEDEMANN SYNDROME	0.0033961899999999995	0.12485020008919158
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0032561729999999994	0.11970291726170301
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0032561729999999994	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0032561729999999994	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0032561729999999994	0.11970291726170301
COFFIN-SIRIS SYNDROME 4; CSS4	0.0032561729999999994	0.11970291726170301
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0032561729999999994	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0032561729999999994	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0032561729999999994	0.11970291726170301
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0032561729999999994	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0032561729999999994	0.11970291726170301
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0032561729999999994	0.11970291726170301
17Q12 MICRODELETION SYNDROME	0.0032561729999999994	0.11970291726170301
ZTTK SYNDROME; ZTTKS	0.0032561729999999994	0.11970291726170301
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0032561729999999994	0.11970291726170301
BOHRING-OPITZ SYNDROME	0.0032561729999999994	0.11970291726170301
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0032561729999999994	0.11970291726170301
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0032561729999999994	0.11970291726170301
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0032561729999999994	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0032561729999999994	0.11970291726170301
WIEACKER-WOLFF SYNDROME	0.0032561729999999994	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0032561729999999994	0.11970291726170301
GAUCHER DISEASE, TYPE II	0.0032561729999999994	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0032561729999999994	0.11970291726170301
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0032561729999999994	0.11970291726170301
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0032561729999999994	0.11970291726170301
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0032561729999999994	0.11970291726170301
COFFIN-SIRIS SYNDROME 2; CSS2	0.0032561729999999994	0.11970291726170301
COFFIN-SIRIS SYNDROME 3; CSS3	0.0032561729999999994	0.11970291726170301
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0032561729999999994	0.11970291726170301
HELSMOORTEL-VAN DER AA SYNDROME	0.0032561729999999994	0.11970291726170301
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0032561729999999994	0.11970291726170301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0032561729999999994	0.11970291726170301
STT3B-CDG	0.0032561729999999994	0.11970291726170301
GENITOPATELLAR SYNDROME	0.0032561729999999994	0.11970291726170301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0032561729999999994	0.11970291726170301
SSR4-CDG	0.0032561729999999994	0.11970291726170301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0032561729999999994	0.11970291726170301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0032561729999999994	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0032561729999999994	0.11970291726170301
KBG SYNDROME	0.0032561729999999994	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0032561729999999994	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0032561729999999994	0.11970291726170301
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0032561729999999994	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0032561729999999994	0.11970291726170301
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0032561729999999994	0.11970291726170301
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0032561729999999994	0.11970291726170301
STT3A-CDG	0.0032561729999999994	0.11970291726170301
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0032561729999999994	0.11970291726170301
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0032561729999999994	0.11970291726170301
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0032561729999999994	0.11970291726170301
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003249644	0.11946289919546342
WAARDENBURG-SHAH SYNDROME	0.003249644	0.11946289919546342
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.003249644	0.11946289919546342
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0032496439999999994	0.11946289919546339
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0032496439999999994	0.11946289919546339
JOUBERT SYNDROME 2	0.0032496439999999994	0.11946289919546339
JOUBERT SYNDROME 8	0.0032496439999999994	0.11946289919546339
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0032496439999999994	0.11946289919546339
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0032496439999999994	0.11946289919546339
JOUBERT SYNDROME 6	0.0032496439999999994	0.11946289919546339
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0032496439999999994	0.11946289919546339
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0032496439999999994	0.11946289919546339
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0032496439999999994	0.11946289919546339
ARIMA SYNDROME	0.0032496439999999994	0.11946289919546339
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0032496439999999994	0.11946289919546339
CYCLIC VOMITING SYNDROME	0.003245509	0.1193108889789064
GM1 GANGLIOSIDOSIS	0.003245509	0.1193108889789064
BETA-KETOTHIOLASE DEFICIENCY	0.003245509	0.1193108889789064
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.003245509	0.1193108889789064
SIALIDOSIS TYPE 1	0.003245509	0.1193108889789064
KALLMANN SYNDROME	0.003245509	0.1193108889789064
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003245509	0.1193108889789064
PELIZAEUS-MERZBACHER DISEASE	0.003245509	0.1193108889789064
METACHROMATIC LEUKODYSTROPHY	0.003245509	0.1193108889789064
METACHROMATIC LEUKODYSTROPHY	0.003245509	0.1193108889789064
TRIPLE A SYNDROME	0.003245509	0.1193108889789064
CAMOS SYNDROME	0.0032455089999999997	0.11931088897890639
DYSEQUILIBRIUM SYNDROME	0.0032455089999999997	0.11931088897890639
LEIGH SYNDROME	0.0032455089999999997	0.11931088897890639
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0032455089999999997	0.11931088897890639
ISOLATED CEREBELLAR AGENESIS	0.0032455089999999997	0.11931088897890639
ANGELMAN SYNDROME	0.0032455089999999997	0.11931088897890639
LAURENCE-MOON SYNDROME	0.0031084199999999998	0.11427124482471383
8Q21.11 MICRODELETION SYNDROME	0.00285831	0.1050767405289272
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00285831	0.1050767405289272
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00285831	0.1050767405289272
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00285831	0.1050767405289272
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00285831	0.1050767405289272
6P22 MICRODELETION SYNDROME	0.00285831	0.1050767405289272
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00285831	0.1050767405289272
CAREY-FINEMAN-ZITER SYNDROME	0.00285831	0.1050767405289272
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00285831	0.1050767405289272
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00285831	0.1050767405289272
HYPOTONIA-CYSTINURIA SYNDROME	0.00285831	0.1050767405289272
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00285831	0.1050767405289272
CARTILAGE-HAIR HYPOPLASIA	0.00285831	0.1050767405289272
DOWN SYNDROME	0.00285831	0.1050767405289272
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00285831	0.1050767405289272
NEUROFACIODIGITORENAL SYNDROME	0.00285831	0.1050767405289272
MONOSOMY 13Q14	0.00285831	0.1050767405289272
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00285831	0.1050767405289272
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.002718293	0.09992945770143863
MATERNAL PHENYLKETONURIA	0.002718293	0.09992945770143863
20Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.09992945770143863
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002718293	0.09992945770143863
6Q25 MICRODELETION SYNDROME	0.002718293	0.09992945770143863
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.002718293	0.09992945770143863
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.002718293	0.09992945770143863
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.09992945770143863
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002718293	0.09992945770143863
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002718293	0.09992945770143863
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.002718293	0.09992945770143863
POTOCKI-SHAFFER SYNDROME	0.002718293	0.09992945770143863
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.002718293	0.09992945770143863
SIALURIA	0.002718293	0.09992945770143863
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002718293	0.09992945770143863
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002718293	0.09992945770143863
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.09992945770143863
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.09992945770143863
OCULOECTODERMAL SYNDROME; OES	0.002718293	0.09992945770143863
MAN1B1-CDG	0.002718293	0.09992945770143863
AL KAISSI SYNDROME; ALKAS	0.002718293	0.09992945770143863
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.002718293	0.09992945770143863
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.002718293	0.09992945770143863
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002718293	0.09992945770143863
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.09992945770143863
15Q24 MICRODELETION SYNDROME	0.002718293	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0027182929999999997	0.09992945770143863
XQ25 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.09992945770143863
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0027182929999999997	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0027182929999999997	0.09992945770143863
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0027182929999999997	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0027182929999999997	0.09992945770143863
DISTAL MONOSOMY 1Q	0.0027182929999999997	0.09992945770143863
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027182929999999997	0.09992945770143863
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0027182929999999997	0.09992945770143863
XQ25 DUPLICATION SYNDROME	0.0027182929999999997	0.09992945770143863
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0027147539999999998	0.09979935754269732
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.09979935754269732
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0027147539999999998	0.09979935754269732
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.09979935754269732
EAR-PATELLA-SHORT STATURE SYNDROME	0.0027147539999999998	0.09979935754269732
OROFACIODIGITAL SYNDROME TYPE 4	0.0027147539999999998	0.09979935754269732
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0027147539999999998	0.09979935754269732
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.09979935754269732
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0027147539999999998	0.09979935754269732
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0027147539999999998	0.09979935754269732
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0027147539999999998	0.09979935754269732
TYSHCHENKO SYNDROME	0.0027147539999999998	0.09979935754269732
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0027147539999999998	0.09979935754269732
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0027147539999999998	0.09979935754269732
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0027147539999999998	0.09979935754269732
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.09979935754269732
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0027147539999999998	0.09979935754269732
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0027147539999999998	0.09979935754269732
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.09979935754269732
POPOV-CHANG SYNDROME; POPCHAS	0.0027147539999999998	0.09979935754269732
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027147539999999998	0.09979935754269732
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0027147539999999998	0.09979935754269732
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0027147539999999998	0.09979935754269732
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0027147539999999998	0.09979935754269732
AURICULOCONDYLAR SYNDROME	0.0027147539999999998	0.09979935754269732
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0027147539999999998	0.09979935754269732
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0027147539999999998	0.09979935754269732
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.09964734732614028
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0027106189999999996	0.09964734732614028
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.09964734732614028
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0027106189999999996	0.09964734732614028
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.09964734732614028
17Q24.2 MICRODELETION SYNDROME	0.0027106189999999996	0.09964734732614028
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0027106189999999996	0.09964734732614028
CRISPONI SYNDROME	0.0027106189999999996	0.09964734732614028
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.09964734732614028
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.09964734732614028
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.09964734732614028
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.09964734732614028
16Q24.3 MICRODELETION SYNDROME	0.0027106189999999996	0.09964734732614028
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.09964734732614028
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0027106189999999996	0.09964734732614028
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.09964734732614028
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0027106189999999996	0.09964734732614028
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.09964734732614028
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00270409	0.09940732925990069
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00270409	0.09940732925990069
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00270409	0.09940732925990069
PIEBALDISM	0.00270409	0.09940732925990069
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00270409	0.09940732925990069
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00270409	0.09940732925990069
ABETALIPOPROTEINEMIA	0.00270409	0.09940732925990069
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00270409	0.09940732925990069
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00270409	0.09940732925990069
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00270409	0.09940732925990069
MUCOLIPIDOSIS TYPE IV	0.00270409	0.09940732925990069
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00270409	0.09940732925990069
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00270409	0.09940732925990069
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00270409	0.09940732925990069
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00270409	0.09940732925990069
KEARNS-SAYRE SYNDROME	0.00270409	0.09940732925990069
JOUBERT SYNDROME 5	0.00270409	0.09940732925990069
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00270409	0.09940732925990069
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00270409	0.09940732925990069
CEREBELLAR HYPOPLASIA	0.00270409	0.09940732925990069
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.002564073	0.09426004643241213
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002564073	0.09426004643241213
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002564073	0.09426004643241213
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.002564073	0.09426004643241213
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.002564073	0.09426004643241213
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.002564073	0.09426004643241213
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002564073	0.09426004643241213
SULFOCYSTEINURIA	0.002564073	0.09426004643241213
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.002564073	0.09426004643241213
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002564073	0.09426004643241213
CENTRAL BILATERAL MACROGYRIA	0.002564073	0.09426004643241213
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002564073	0.09426004643241213
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002564073	0.09426004643241213
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002564073	0.09426004643241213
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002564073	0.09426004643241213
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.002564073	0.09426004643241213
NIEMANN-PICK DISEASE TYPE C	0.002564073	0.09426004643241213
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002564073	0.09426004643241213
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002564073	0.09426004643241213
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002564073	0.09426004643241213
EAST SYNDROME	0.002564073	0.09426004643241213
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002564073	0.09426004643241213
MYHRE SYNDROME	0.002564073	0.09426004643241213
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002564073	0.09426004643241213
CITRULLINEMIA, CLASSIC	0.0025640729999999996	0.09426004643241212
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0025640729999999996	0.09426004643241212
CEDNIK SYNDROME	0.0025640729999999996	0.09426004643241212
SRD5A3-CDG	0.0025640729999999996	0.09426004643241212
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0025640729999999996	0.09426004643241212
SIALIDOSIS TYPE 2	0.0025640729999999996	0.09426004643241212
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0025640729999999996	0.09426004643241212
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0025640729999999996	0.09426004643241212
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0025640729999999996	0.09426004643241212
COWDEN SYNDROME	0.0025640729999999996	0.09426004643241212
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.0025640729999999996	0.09426004643241212
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.0025640729999999996	0.09426004643241212
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0025640729999999996	0.09426004643241212
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0025640729999999996	0.09426004643241212
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0025640729999999996	0.09426004643241212
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.0025640729999999996	0.09426004643241212
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0025640729999999996	0.09426004643241212
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0025640729999999996	0.09426004643241212
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0025640729999999996	0.09426004643241212
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0025640729999999996	0.09426004643241212
CHROMOSOME 1P35 DELETION SYNDROME	0.0025640729999999996	0.09426004643241212
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.0025640729999999996	0.09426004643241212
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.0025640729999999996	0.09426004643241212
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0025640729999999996	0.09426004643241212
CHÉDIAK-HIGASHI SYNDROME	0.0025640729999999996	0.09426004643241212
GALLOWAY-MOWAT SYNDROME	0.002313963	0.08506554213662547
FILIPPI SYNDROME	0.002313963	0.08506554213662547
FUCOSIDOSIS	0.002313963	0.08506554213662547
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.002313963	0.08506554213662547
ISOLATED GLYCEROL KINASE DEFICIENCY	0.002313963	0.08506554213662547
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002313963	0.08506554213662547
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.002313963	0.08506554213662547
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002313963	0.08506554213662547
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.002313963	0.08506554213662547
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002313963	0.08506554213662547
CHROMOSOME 16P13.2 DELETION SYNDROME	0.002313963	0.08506554213662547
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.002313963	0.08506554213662547
CODAS SYNDROME	0.002313963	0.08506554213662547
3Q29 MICRODUPLICATION SYNDROME	0.002313963	0.08506554213662547
LEBER CONGENITAL AMAUROSIS	0.002313963	0.08506554213662547
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002313963	0.08506554213662547
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.002313963	0.08506554213662547
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002313963	0.08506554213662547
2Q37 MICRODELETION SYNDROME	0.002313963	0.08506554213662547
GRISCELLI SYNDROME, TYPE 1	0.002313963	0.08506554213662547
KLEEFSTRA SYNDROME 2; KLEFS2	0.002313963	0.08506554213662547
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.002313963	0.08506554213662547
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.002313963	0.08506554213662547
ALG3-CDG	0.002313963	0.08506554213662547
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.002313963	0.08506554213662547
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002313963	0.08506554213662547
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.002313963	0.08506554213662547
RECOMBINANT CHROMOSOME 8 SYNDROME	0.002313963	0.08506554213662547
WALKER-WARBURG SYNDROME	0.002313963	0.08506554213662547
1Q21.1 MICRODUPLICATION SYNDROME	0.002313963	0.08506554213662547
DPAGT1-CDG	0.002313963	0.08506554213662547
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002313963	0.08506554213662547
CONGENITAL TOXOPLASMOSIS	0.002313963	0.08506554213662547
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.002313963	0.08506554213662547
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.002313963	0.08506554213662547
MICRO SYNDROME	0.002313963	0.08506554213662547
2P21 MICRODELETION SYNDROME	0.002313963	0.08506554213662547
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.002313963	0.08506554213662547
INCONTINENTIA PIGMENTI	0.002313963	0.08506554213662547
VICI SYNDROME; VICIS	0.002313963	0.08506554213662547
MULTIPLE CARBOXYLASE DEFICIENCY	0.002313963	0.08506554213662547
SCHINDLER DISEASE, TYPE I	0.002313963	0.08506554213662547
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.002313963	0.08506554213662547
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.002313963	0.08506554213662547
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.002313963	0.08506554213662547
KETOADIPICACIDURIA	0.002313963	0.08506554213662547
ADAMS-OLIVER SYNDROME 1; AOS1	0.002313963	0.08506554213662547
PYRUVATE CARBOXYLASE DEFICIENCY	0.002313963	0.08506554213662547
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.002313963	0.08506554213662547
SEVERE CANAVAN DISEASE	0.002313963	0.08506554213662547
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.08002589798243291
LIG4 SYNDROME	0.0021768739999999996	0.08002589798243291
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0021768739999999996	0.08002589798243291
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.08002589798243291
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.08002589798243291
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.08002589798243291
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021768739999999996	0.08002589798243291
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0021768739999999996	0.08002589798243291
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.08002589798243291
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.08002589798243291
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.08002589798243291
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.08002589798243291
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.08002589798243291
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.08002589798243291
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0021768739999999996	0.08002589798243291
BARATELA-SCOTT SYNDROME	0.0021768739999999996	0.08002589798243291
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.08002589798243291
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.08002589798243291
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.08002589798243291
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.08002589798243291
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.08002589798243291
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.08002589798243291
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.08002589798243291
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.08002589798243291
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.08002589798243291
OGDEN SYNDROME; OGDNS	0.0021768739999999996	0.08002589798243291
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.08002589798243291
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.08002589798243291
MONOSOMY 13Q34	0.0021768739999999996	0.08002589798243291
DISTAL MONOSOMY 6P	0.0021768739999999996	0.08002589798243291
WARSAW BREAKAGE SYNDROME; WABS	0.0021768739999999996	0.08002589798243291
FANCONI ANEMIA	0.0021768739999999996	0.08002589798243291
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0021768739999999996	0.08002589798243291
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.08002589798243291
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.08002589798243291
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.08002589798243291
ICF SYNDROME	0.0021768739999999996	0.08002589798243291
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0021768739999999996	0.08002589798243291
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.08002589798243291
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.08002589798243291
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0021768739999999996	0.08002589798243291
VASCULAR EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.08002589798243291
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.08002589798243291
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.08002589798243291
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0021768739999999996	0.08002589798243291
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0021768739999999996	0.08002589798243291
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.08002589798243291
FETAL HYDANTOIN SYNDROME	0.0021768739999999996	0.08002589798243291
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.08002589798243291
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0021768739999999996	0.08002589798243291
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.08002589798243291
TRISOMY 12P	0.0021768739999999996	0.08002589798243291
PHENOBARBITAL EMBRYOPATHY	0.0021768739999999996	0.08002589798243291
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.08002589798243291
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.08002589798243291
FETAL TRIMETHADIONE SYNDROME	0.0021768739999999996	0.08002589798243291
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.08002589798243291
ROTHMUND-THOMSON SYNDROME	0.0021768739999999996	0.08002589798243291
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.002172739	0.0798738877658759
TETRASOMY 18P	0.002172739	0.0798738877658759
CHIME SYNDROME	0.002172739	0.0798738877658759
MOMO SYNDROME	0.002172739	0.0798738877658759
FOUNTAIN SYNDROME	0.002172739	0.0798738877658759
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.0798738877658759
KNOBLOCH SYNDROME	0.002172739	0.0798738877658759
OROFACIODIGITAL SYNDROME I; OFD1	0.002172739	0.0798738877658759
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.002172739	0.0798738877658759
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002172739	0.0798738877658759
DUBOWITZ SYNDROME	0.002172739	0.0798738877658759
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.002172739	0.0798738877658759
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.0798738877658759
SAETHRE-CHOTZEN SYNDROME	0.002172739	0.0798738877658759
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.002172739	0.0798738877658759
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.0798738877658759
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.002172739	0.0798738877658759
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002172739	0.0798738877658759
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.0798738877658759
HENNEKAM SYNDROME	0.002172739	0.0798738877658759
RENPENNING SYNDROME	0.002172739	0.0798738877658759
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002172739	0.0798738877658759
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.002172739	0.0798738877658759
MECKEL SYNDROME, TYPE 10; MKS10	0.002172739	0.0798738877658759
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.07974378760713458
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.07974378760713458
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.07974378760713458
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.07974378760713458
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.07974378760713458
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.07974378760713458
FONTAINE PROGEROID SYNDROME; FPS	0.0021691999999999996	0.07974378760713458
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.07974378760713458
BETA-THALASSEMIA MAJOR	0.0021691999999999996	0.07974378760713458
LOCKED-IN SYNDROME	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.07974378760713458
CRISS-CROSS HEART	0.0021691999999999996	0.07974378760713458
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0021691999999999996	0.07974378760713458
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.07974378760713458
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.07974378760713458
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.07974378760713458
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.07974378760713458
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.07974378760713458
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.07974378760713458
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.07974378760713458
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.07974378760713458
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.07974378760713458
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.07974378760713458
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.07974378760713458
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.07974378760713458
CHOANAL ATRESIA	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.07974378760713458
SANDIFER SYNDROME	0.0021691999999999996	0.07974378760713458
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.07974378760713458
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.07974378760713458
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.07974378760713458
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.07974378760713458
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.07974378760713458
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.07974378760713458
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.07974378760713458
CHARGE SYNDROME	0.0021691999999999996	0.07974378760713458
MEIER-GORLIN SYNDROME 6; MGORS6	0.0021691999999999996	0.07974378760713458
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.07974378760713458
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.07974378760713458
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.07974378760713458
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.07974378760713458
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.07974378760713458
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.07974378760713458
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.07974378760713458
MEIER-GORLIN SYNDROME 3; MGORS3	0.0021691999999999996	0.07974378760713458
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.07974378760713458
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.07974378760713458
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07435648671340639
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.0020226539999999996	0.07435648671340639
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07435648671340639
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07435648671340639
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 21	0.0020226539999999996	0.07435648671340639
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07435648671340639
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0020226539999999996	0.07435648671340639
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0020226539999999996	0.07435648671340639
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07435648671340639
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 7	0.0020226539999999996	0.07435648671340639
IMMUNODEFICIENCY 23; IMD23	0.0020226539999999996	0.07435648671340639
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 27	0.0020226539999999996	0.07435648671340639
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 28	0.0020226539999999996	0.07435648671340639
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0020226539999999996	0.07435648671340639
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07435648671340639
BARDET-BIEDL SYNDROME 1; BBS1	0.0020226539999999996	0.07435648671340639
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07435648671340639
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07435648671340639
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07435648671340639
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0020226539999999996	0.07435648671340639
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0020226539999999996	0.07435648671340639
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 15	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07435648671340639
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0020226539999999996	0.07435648671340639
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07435648671340639
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 25	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07435648671340639
PEROXISOME BIOGENESIS DISORDER 6B	0.0020226539999999996	0.07435648671340639
SENIOR-LOKEN SYNDROME	0.0020226539999999996	0.07435648671340639
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07435648671340639
NAVAJO NEUROHEPATOPATHY	0.0020226539999999996	0.07435648671340639
HOYERAAL-HREIDARSSON SYNDROME	0.0020226539999999996	0.07435648671340639
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0020226539999999996	0.07435648671340639
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07435648671340639
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07435648671340639
FLYNN-AIRD SYNDROME	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.07420447649684939
LISSENCEPHALY 3; LIS3	0.002018519	0.07420447649684939
ALEXANDER DISEASE	0.002018519	0.07420447649684939
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07420447649684939
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07420447649684939
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.07420447649684939
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07420447649684939
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.002018519	0.07420447649684939
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.002018519	0.07420447649684939
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.002018519	0.07420447649684939
RETT SYNDROME	0.002018519	0.07420447649684939
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07420447649684939
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07420447649684939
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002018519	0.07420447649684939
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.07420447649684939
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.07420447649684939
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.002018519	0.07420447649684939
XERODERMA PIGMENTOSUM	0.002018519	0.07420447649684939
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.07420447649684939
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.002018519	0.07420447649684939
SANDHOFF DISEASE	0.002018519	0.07420447649684939
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.07420447649684939
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.002018519	0.07420447649684939
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.002018519	0.07420447649684939
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.002018519	0.07420447649684939
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002018519	0.07420447649684939
KUFOR-RAKEB SYNDROME	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.07420447649684939
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.07420447649684939
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07420447649684939
TYROSINEMIA TYPE 2	0.002018519	0.07420447649684939
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07420447649684939
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.07420447649684939
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07420447649684939
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.07420447649684939
COCKAYNE SYNDROME A; CSA	0.002018519	0.07420447649684939
ATAXIA-TELANGIECTASIA	0.002018519	0.07420447649684939
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.07420447649684939
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.07420447649684939
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.07420447649684939
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07420447649684939
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07420447649684939
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.07420447649684939
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.07420447649684939
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07420447649684939
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.002018519	0.07420447649684939
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07420447649684939
THYROCEREBRORETINAL SYNDROME	0.002018519	0.07420447649684939
HEREDITARY HYPEREKPLEXIA	0.002018519	0.07420447649684939
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.07420447649684939
MUCOPOLYSACCHARIDOSIS TYPE 3	0.002018519	0.07420447649684939
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07420447649684939
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.07420447649684939
BEHÇET DISEASE	0.002018519	0.07420447649684939
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.002018519	0.07420447649684939
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.07420447649684939
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002018519	0.07420447649684939
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07420447649684939
FLYNN-AIRD SYNDROME	0.002018519	0.07420447649684939
EPISODIC ATAXIA TYPE 6	0.002018519	0.07420447649684939
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.07420447649684939
WHIPPLE DISEASE	0.002018519	0.07420447649684939
DILATED CARDIOMYOPATHY WITH ATAXIA	0.002018519	0.07420447649684939
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.07420447649684939
MEGALENCEPHALY WITH DYSMYELINATION	0.002018519	0.07420447649684939
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07420447649684939
DIAMINOPENTANURIA	0.002018519	0.07420447649684939
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.002018519	0.07420447649684939
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.07420447649684939
ROIFMAN SYNDROME; RFMN	0.001772544	0.06516198241761975
CRANIOSYNOSTOSIS 6; CRS6	0.001772544	0.06516198241761975
17P11.2 MICRODUPLICATION SYNDROME	0.001772544	0.06516198241761975
20Q11.2 MICRODELETION SYNDROME	0.001772544	0.06516198241761975
GENITOPATELLAR SYNDROME; GTPTS	0.001772544	0.06516198241761975
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001772544	0.06516198241761975
PEROXISOME BIOGENESIS DISORDER 3B	0.001772544	0.06516198241761975
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001772544	0.06516198241761975
17P13.3 MICRODUPLICATION SYNDROME	0.001772544	0.06516198241761975
COLE-CARPENTER SYNDROME	0.001772544	0.06516198241761975
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001772544	0.06516198241761975
GERODERMA OSTEODYSPLASTICA	0.001772544	0.06516198241761975
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001772544	0.06516198241761975
GERMAN SYNDROME	0.001772544	0.06516198241761975
12Q14 MICRODELETION SYNDROME	0.001772544	0.06516198241761975
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.001772544	0.06516198241761975
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001772544	0.06516198241761975
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001772544	0.06516198241761975
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001772544	0.06516198241761975
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001772544	0.06516198241761975
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06516198241761975
XQ27.3Q28 DUPLICATION SYNDROME	0.001772544	0.06516198241761975
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001772544	0.06516198241761975
CRANIOFRONTONASAL SYNDROME; CFNS	0.001772544	0.06516198241761975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001772544	0.06516198241761975
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001772544	0.06516198241761975
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.001772544	0.06516198241761975
FRIED SYNDROME	0.001772544	0.06516198241761975
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06516198241761975
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001772544	0.06516198241761975
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.001772544	0.06516198241761975
RITSCHER-SCHINZEL SYNDROME 1	0.001772544	0.06516198241761975
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001772544	0.06516198241761975
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001772544	0.06516198241761975
ALG6-CDG	0.001772544	0.06516198241761975
PENTASOMY X	0.001772544	0.06516198241761975
ALPHA-MANNOSIDOSIS	0.001772544	0.06516198241761975
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001772544	0.06516198241761975
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001772544	0.06516198241761975
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001772544	0.06516198241761975
MICROPHTHALMIA, SYNDROMIC 3	0.001772544	0.06516198241761975
GALACTOSE EPIMERASE DEFICIENCY	0.001772544	0.06516198241761975
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001772544	0.06516198241761975
MUCOLIPIDOSIS IV; ML4	0.001772544	0.06516198241761975
THANATOPHORIC DYSPLASIA, TYPE I	0.001772544	0.06516198241761975
TRANSKETOLASE DEFICIENCY	0.001772544	0.06516198241761975
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001772544	0.06516198241761975
HYPERLYSINEMIA, TYPE I	0.001768409	0.06500997220106274
HADDAD SYNDROME	0.001768409	0.06500997220106274
MPDU1-CDG	0.001768409	0.06500997220106274
GLYCINE ENCEPHALOPATHY; GCE	0.001768409	0.06500997220106274
INFANTILE NEUROAXONAL DYSTROPHY	0.001768409	0.06500997220106274
L-2-HYDROXYGLUTARIC ACIDURIA	0.001768409	0.06500997220106274
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001768409	0.06500997220106274
ONDINE SYNDROME	0.001768409	0.06500997220106274
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001768409	0.06500997220106274
KRABBE DISEASE	0.001768409	0.06500997220106274
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.001768409	0.06500997220106274
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001768409	0.06500997220106274
LINEAR NEVUS SEBACEUS SYNDROME	0.001768409	0.06500997220106274
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.001768409	0.06500997220106274
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.001768409	0.06500997220106274
CONGENITAL RUBELLA SYNDROME	0.001768409	0.06500997220106274
1P36 MICRODELETION SYNDROME	0.001768409	0.06500997220106274
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.001768409	0.06500997220106274
ALG9-CDG	0.001768409	0.06500997220106274
ZIMMERMANN-LABAND SYNDROME 1	0.001768409	0.06500997220106274
GLUTARIC ACIDEMIA I; GA1	0.001768409	0.06500997220106274
MUSCLE-EYE-BRAIN DISEASE	0.001768409	0.06500997220106274
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.001768409	0.06500997220106274
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.001768409	0.06500997220106274
BENIGN FAMILIAL INFANTILE EPILEPSY	0.001768409	0.06500997220106274
SJÖGREN-LARSSON SYNDROME	0.001768409	0.06500997220106274
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06500997220106274
ISOLATED SPINA BIFIDA	0.001768409	0.06500997220106274
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.001768409	0.06500997220106274
THANATOPHORIC DYSPLASIA	0.001768409	0.06500997220106274
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.001768409	0.06500997220106274
NORRIE DISEASE	0.001768409	0.06500997220106274
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.001768409	0.06500997220106274
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001768409	0.06500997220106274
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.001768409	0.06500997220106274
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06500997220106274
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06500997220106274
FRAGILE X SYNDROME	0.001768409	0.06500997220106274
FETAL GAUCHER DISEASE	0.001768409	0.06500997220106274
VISCERAL STEATOSIS, CONGENITAL	0.001768409	0.06500997220106274
CENTRONUCLEAR MYOPATHY	0.001768409	0.06500997220106274
WOLF-HIRSCHHORN SYNDROME	0.001768409	0.06500997220106274
DISTAL MONOSOMY 7Q36	0.001768409	0.06500997220106274
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.001768409	0.06500997220106274
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001768409	0.06500997220106274
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06500997220106274
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.001768409	0.06500997220106274
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001768409	0.06500997220106274
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.001768409	0.06500997220106274
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.001768409	0.06500997220106274
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.001768409	0.06500997220106274
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06500997220106274
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06500997220106274
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06500997220106274
THANATOPHORIC DYSPLASIA TYPE 1	0.001768409	0.06500997220106274
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.05997032804687017
OMODYSPLASIA 1; OMOD1	0.00163132	0.05997032804687017
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.05997032804687017
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.05997032804687017
SCARF SYNDROME	0.00163132	0.05997032804687017
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.05997032804687017
PTERYGIUM COLLI, ISOLATED	0.00163132	0.05997032804687017
SCARF SYNDROME	0.00163132	0.05997032804687017
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.05997032804687017
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.05997032804687017
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.05997032804687017
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.05997032804687017
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.05997032804687017
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00163132	0.05997032804687017
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.05997032804687017
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.05997032804687017
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.05997032804687017
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.05997032804687017
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.05997032804687017
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.05997032804687017
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00163132	0.05997032804687017
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.05997032804687017
SILLENCE SYNDROME	0.00163132	0.05997032804687017
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.05997032804687017
ACRORENAL-MANDIBULAR SYNDROME	0.00163132	0.05997032804687017
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.05997032804687017
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.05997032804687017
NOONAN SYNDROME 4; NS4	0.00163132	0.05997032804687017
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00163132	0.05997032804687017
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00163132	0.05997032804687017
MILROY DISEASE	0.00163132	0.05997032804687017
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.05997032804687017
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.05997032804687017
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.05997032804687017
RING CHROMOSOME 6 SYNDROME	0.00163132	0.05997032804687017
CRANIOECTODERMAL DYSPLASIA 1	0.00163132	0.05997032804687017
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.05997032804687017
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00163132	0.05997032804687017
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.05997032804687017
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.05997032804687017
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.05997032804687017
SCHOLTE SYNDROME; SHLTS	0.00163132	0.05997032804687017
BRITTLE CORNEA SYNDROME	0.00163132	0.05997032804687017
BRADDOCK SYNDROME	0.00163132	0.05997032804687017
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.05997032804687017
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.05997032804687017
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.05997032804687017
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.05997032804687017
BALLER-GEROLD SYNDROME	0.00163132	0.05997032804687017
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00163132	0.05997032804687017
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.05997032804687017
ATELOSTEOGENESIS TYPE II	0.00163132	0.05997032804687017
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.05997032804687017
ACROOTOOCULAR SYNDROME	0.00163132	0.05997032804687017
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.05997032804687017
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.05997032804687017
RING CHROMOSOME 8 SYNDROME	0.00163132	0.05997032804687017
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.05997032804687017
PENOSCROTAL TRANSPOSITION	0.00163132	0.05997032804687017
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.05997032804687017
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.05997032804687017
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.05997032804687017
LEGIUS SYNDROME	0.00163132	0.05997032804687017
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.05997032804687017
NOONAN SYNDROME 8; NS8	0.00163132	0.05997032804687017
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00163132	0.05997032804687017
LICHTENSTEIN SYNDROME	0.00163132	0.05997032804687017
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00163132	0.05997032804687017
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.05997032804687017
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.05997032804687017
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.05997032804687017
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00163132	0.05997032804687017
PHAVER SYNDROME	0.00163132	0.05997032804687017
CEREBROOCULONASAL SYNDROME	0.00163132	0.05997032804687017
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.05997032804687017
SUMMITT SYNDROME	0.00163132	0.05997032804687017
600736 VELOFACIOSKELETAL SYNDROME	0.00163132	0.05997032804687017
RENAL AGENESIS, BILATERAL	0.00163132	0.05997032804687017
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.05997032804687017
EPICANTHUS	0.00163132	0.05997032804687017
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.05997032804687017
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.05997032804687017
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.05997032804687017
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00163132	0.05997032804687017
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.05997032804687017
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.05997032804687017
RING CHROMOSOME 13 SYNDROME	0.00163132	0.05997032804687017
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.05997032804687017
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.05997032804687017
MONOSOMY 22	0.00163132	0.05997032804687017
DISTAL TRISOMY 5Q	0.00163132	0.05997032804687017
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.05997032804687017
JACOBSEN SYNDROME	0.00163132	0.05997032804687017
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.05997032804687017
KEIPERT SYNDROME	0.00163132	0.05997032804687017
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.05997032804687017
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.05997032804687017
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.05997032804687017
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.05997032804687017
MYOTONIA PERMANENS	0.00163132	0.05997032804687017
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.05997032804687017
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.05997032804687017
VELO-FACIAL-SKELETAL SYNDROME	0.00163132	0.05997032804687017
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.05997032804687017
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.05997032804687017
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.05997032804687017
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.05997032804687017
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.05997032804687017
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00163132	0.05997032804687017
DIAMOND-BLACKFAN ANEMIA 1	0.00163132	0.05997032804687017
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.05997032804687017
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00163132	0.05997032804687017
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.05997032804687017
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.05997032804687017
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.05997032804687017
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00163132	0.05997032804687017
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.05997032804687017
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.05997032804687017
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.05997032804687017
OROFACIAL CLEFT 15	0.00163132	0.05997032804687017
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.05997032804687017
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.05997032804687017
JUBERG-MARSIDI SYNDROME	0.00163132	0.05997032804687017
FETAL VALPROATE SYNDROME	0.00163132	0.05997032804687017
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00163132	0.05997032804687017
CEREBROOCULONASAL SYNDROME	0.00163132	0.05997032804687017
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.05997032804687017
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00163132	0.05997032804687017
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.05997032804687017
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.05997032804687017
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.05997032804687017
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.05997032804687017
FEINGOLD SYNDROME 1; FGLDS1	0.00163132	0.05997032804687017
FRONTORHINY	0.00163132	0.05997032804687017
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.05997032804687017
ACRODYSOSTOSIS	0.00163132	0.05997032804687017
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00163132	0.05997032804687017
ERDHEIM-CHESTER DISEASE	0.0014770999999999999	0.05430091677784367
STIMMLER SYNDROME	0.0014770999999999999	0.05430091677784367
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05430091677784367
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.05430091677784367
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05430091677784367
KIKUCHI-FUJIMOTO DISEASE	0.0014770999999999999	0.05430091677784367
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05430091677784367
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05430091677784367
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0014770999999999999	0.05430091677784367
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05430091677784367
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05430091677784367
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05430091677784367
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05430091677784367
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.05430091677784367
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.0014770999999999999	0.05430091677784367
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0014770999999999999	0.05430091677784367
PITUITARY CARCINOMA	0.0014770999999999999	0.05430091677784367
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05430091677784367
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05430091677784367
GEMIGNANI SYNDROME	0.0014770999999999999	0.05430091677784367
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.05430091677784367
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.05430091677784367
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.05430091677784367
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05430091677784367
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0014770999999999999	0.05430091677784367
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.05430091677784367
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05430091677784367
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05430091677784367
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.05430091677784367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05430091677784367
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.05430091677784367
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05430091677784367
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.05430091677784367
CLASSIC HODGKIN LYMPHOMA	0.0014770999999999999	0.05430091677784367
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0014770999999999999	0.05430091677784367
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05430091677784367
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05430091677784367
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.05430091677784367
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05430091677784367
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.05430091677784367
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05430091677784367
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0014770999999999999	0.05430091677784367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05430091677784367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.05430091677784367
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05430091677784367
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.05430091677784367
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05430091677784367
CHANARIN-DORFMAN SYNDROME	0.0014770999999999999	0.05430091677784367
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0014770999999999999	0.05430091677784367
REFSUM DISEASE	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05430091677784367
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.05430091677784367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05430091677784367
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05430091677784367
CHAND SYNDROME	0.0014770999999999999	0.05430091677784367
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.05430091677784367
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0014770999999999999	0.05430091677784367
ACERULOPLASMINEMIA	0.0014770999999999999	0.05430091677784367
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05430091677784367
SANDHOFF DISEASE	0.0014770999999999999	0.05430091677784367
WALDENSTRÖM MACROGLOBULINEMIA	0.0014770999999999999	0.05430091677784367
LEGIONELLOSIS	0.0014770999999999999	0.05430091677784367
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05430091677784367
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05430091677784367
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0014770999999999999	0.05430091677784367
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05430091677784367
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05430091677784367
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05430091677784367
VON HIPPEL-LINDAU DISEASE	0.0014770999999999999	0.05430091677784367
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05430091677784367
USHER SYNDROME	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.05430091677784367
ACERULOPLASMINEMIA	0.0014770999999999999	0.05430091677784367
AGEL AMYLOIDOSIS	0.0014770999999999999	0.05430091677784367
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05430091677784367
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05430091677784367
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05430091677784367
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0014770999999999999	0.05430091677784367
HEREDITARY SPHEROCYTOSIS	0.0014770999999999999	0.05430091677784367
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05430091677784367
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05430091677784367
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05430091677784367
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05430091677784367
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.05430091677784367
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.05430091677784367
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05430091677784367
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05430091677784367
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.05430091677784367
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05430091677784367
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05430091677784367
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05430091677784367
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.05430091677784367
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05430091677784367
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05430091677784367
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.05430091677784367
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.05430091677784367
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0014770999999999999	0.05430091677784367
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05430091677784367
RAVINE SYNDROME	0.0014770999999999999	0.05430091677784367
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05430091677784367
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05430091677784367
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.05430091677784367
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.05430091677784367
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.05430091677784367
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05430091677784367
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05430091677784367
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05430091677784367
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0014770999999999999	0.05430091677784367
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.05430091677784367
HODGKIN LYMPHOMA	0.0014770999999999999	0.05430091677784367
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05430091677784367
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.05430091677784367
JOUBERT SYNDROME 4	0.0014770999999999999	0.05430091677784367
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.05430091677784367
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05430091677784367
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.05430091677784367
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05430091677784367
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05430091677784367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05430091677784367
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05430091677784367
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.05430091677784367
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05430091677784367
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05430091677784367
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.05430091677784367
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.05430091677784367
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.05430091677784367
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05430091677784367
RHOMBENCEPHALOSYNAPSIS	0.0014770999999999999	0.05430091677784367
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05430091677784367
PENDRED SYNDROME	0.0014770999999999999	0.05430091677784367
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05430091677784367
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05430091677784367
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05430091677784367
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05430091677784367
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05430091677784367
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.05430091677784367
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.05430091677784367
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.05430091677784367
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05430091677784367
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05430091677784367
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05430091677784367
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05430091677784367
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0014770999999999999	0.05430091677784367
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0014770999999999999	0.05430091677784367
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0014770999999999999	0.05430091677784367
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.05430091677784367
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00122699	0.04510641248205701
HYPERCALCEMIA, INFANTILE 2	0.00122699	0.04510641248205701
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00122699	0.04510641248205701
FETAL METHYLMERCURY SYNDROME	0.00122699	0.04510641248205701
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00122699	0.04510641248205701
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.04510641248205701
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00122699	0.04510641248205701
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00122699	0.04510641248205701
JOHANSON-BLIZZARD SYNDROME; JBS	0.00122699	0.04510641248205701
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00122699	0.04510641248205701
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00122699	0.04510641248205701
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.04510641248205701
LAMBERT SYNDROME	0.00122699	0.04510641248205701
GLYCOGEN STORAGE DISEASE II	0.00122699	0.04510641248205701
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.04510641248205701
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00122699	0.04510641248205701
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00122699	0.04510641248205701
ERMINE PHENOTYPE	0.00122699	0.04510641248205701
9Q SUBTELOMERIC DELETION SYNDROME	0.00122699	0.04510641248205701
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.00122699	0.04510641248205701
SMITH-MAGENIS SYNDROME	0.00122699	0.04510641248205701
MENTAL RETARDATION, X-LINKED 93	0.00122699	0.04510641248205701
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.04510641248205701
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00122699	0.04510641248205701
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00122699	0.04510641248205701
CAMPOMELIC DYSPLASIA	0.00122699	0.04510641248205701
CENTRAL CORE DISEASE	0.00122699	0.04510641248205701
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00122699	0.04510641248205701
LESCH-NYHAN SYNDROME; LNS	0.00122699	0.04510641248205701
CAT-EYE SYNDROME	0.00122699	0.04510641248205701
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00122699	0.04510641248205701
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.04510641248205701
DIASTROPHIC DWARFISM	0.00122699	0.04510641248205701
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00122699	0.04510641248205701
SPONASTRIME DYSPLASIA	0.00122699	0.04510641248205701
CRANIOFRONTONASAL DYSPLASIA	0.00122699	0.04510641248205701
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00122699	0.04510641248205701
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00122699	0.04510641248205701
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00122699	0.04510641248205701
ACID PHOSPHATASE DEFICIENCY	0.00122699	0.04510641248205701
GLYCOGEN STORAGE DISEASE IV	0.00122699	0.04510641248205701
DESBUQUOIS DYSPLASIA 1	0.00122699	0.04510641248205701
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00122699	0.04510641248205701
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00122699	0.04510641248205701
ANTISYNTHETASE SYNDROME	0.00122699	0.04510641248205701
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00122699	0.04510641248205701
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00122699	0.04510641248205701
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00122699	0.04510641248205701
COG7-CDG	0.00122699	0.04510641248205701
B4GALT1-CDG	0.00122699	0.04510641248205701
OPSISMODYSPLASIA; OPSMD	0.00122699	0.04510641248205701
ALG12-CDG	0.00122699	0.04510641248205701
COOPER-JABS SYNDROME	0.00122699	0.04510641248205701
ACHONDROPLASIA	0.00122699	0.04510641248205701
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00122699	0.04510641248205701
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00122699	0.04510641248205701
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00122699	0.04510641248205701
SENGERS SYNDROME	0.00122699	0.04510641248205701
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00122699	0.04510641248205701
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00122699	0.04510641248205701
IMAGE SYNDROME	0.00122699	0.04510641248205701
PSEUDOTRISOMY 13 SYNDROME	0.00122699	0.04510641248205701
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00122699	0.04510641248205701
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00122699	0.04510641248205701
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00122699	0.04510641248205701
KYPHOMELIC DYSPLASIA	0.00122699	0.04510641248205701
INTESTINAL BOTULISM	0.00122699	0.04510641248205701
THAKKER-DONNAI SYNDROME	0.00122699	0.04510641248205701
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00122699	0.04510641248205701
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00122699	0.04510641248205701
TETRASOMY 12P	0.00122699	0.04510641248205701
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00122699	0.04510641248205701
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00122699	0.04510641248205701
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00122699	0.04510641248205701
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.00122699	0.04510641248205701
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.04510641248205701
TRISOMY 4P	0.00122699	0.04510641248205701
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.04510641248205701
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.04510641248205701
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.04510641248205701
PEARSON SYNDROME	0.00122699	0.04510641248205701
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00122699	0.04510641248205701
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00122699	0.04510641248205701
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.04510641248205701
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00122699	0.04510641248205701
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00122699	0.04510641248205701
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.04510641248205701
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00122699	0.04510641248205701
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00122699	0.04510641248205701
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00122699	0.04510641248205701
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00122699	0.04510641248205701
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.04510641248205701
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00122699	0.04510641248205701
MARSHALL-SMITH SYNDROME; MRSHSS	0.00122699	0.04510641248205701
WARBURG MICRO SYNDROME 1	0.00122699	0.04510641248205701
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04510641248205701
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00122699	0.04510641248205701
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00122699	0.04510641248205701
PORPHYRIA, ACUTE HEPATIC	0.00122699	0.04510641248205701
NEMALINE MYOPATHY 7; NEM7	0.00122699	0.04510641248205701
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00122699	0.04510641248205701
IMMUNODEFICIENCY 9; IMD9	0.00122699	0.04510641248205701
MACS SYNDROME	0.00122699	0.04510641248205701
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00122699	0.04510641248205701
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00122699	0.04510641248205701
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00122699	0.04510641248205701
HAWKINSINURIA	0.00122699	0.04510641248205701
FAMILIAL LAMBDOID SYNOSTOSIS	0.00122699	0.04510641248205701
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.04510641248205701
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00122699	0.04510641248205701
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.04510641248205701
MATTHEW-WOOD SYNDROME	0.00122699	0.04510641248205701
LAURIN-SANDROW SYNDROME	0.00122699	0.04510641248205701
JOHANSON-BLIZZARD SYNDROME	0.00122699	0.04510641248205701
JUNG SYNDROME	0.00122699	0.04510641248205701
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.04510641248205701
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00122699	0.04510641248205701
ISOTRETINOIN SYNDROME	0.00122699	0.04510641248205701
GRANT SYNDROME	0.00122699	0.04510641248205701
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00122699	0.04510641248205701
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00122699	0.04510641248205701
PIERSON SYNDROME	0.00122699	0.04510641248205701
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00122699	0.04510641248205701
STEINERT MYOTONIC DYSTROPHY	0.00122699	0.04510641248205701
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.03995912965456846
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.03995912965456846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.03995912965456846
WAISMAN SYNDROME; WSMN	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.03995912965456846
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.03995912965456846
SCHIZENCEPHALY	0.001086973	0.03995912965456846
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03995912965456846
MOSAIC TRISOMY 14	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.03995912965456846
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.03995912965456846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.03995912965456846
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.03995912965456846
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.03995912965456846
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.03995912965456846
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03995912965456846
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.03995912965456846
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03995912965456846
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.03995912965456846
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03995912965456846
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.03995912965456846
RUVALCABA SYNDROME	0.001086973	0.03995912965456846
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.03995912965456846
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03995912965456846
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.03995912965456846
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03995912965456846
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.03995912965456846
L1 SYNDROME	0.001086973	0.03995912965456846
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.03995912965456846
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.03995912965456846
DIGEORGE SYNDROME; DGS	0.001086973	0.03995912965456846
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.03995912965456846
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03995912965456846
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.03995912965456846
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.03995912965456846
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.03995912965456846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.03995912965456846
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03995912965456846
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.03995912965456846
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03995912965456846
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03995912965456846
DISTAL MONOSOMY 15Q	0.001086973	0.03995912965456846
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03995912965456846
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.03995912965456846
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.03995912965456846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03995912965456846
KEUTEL SYNDROME	0.001086973	0.03995912965456846
ARGININEMIA	0.001086973	0.03995912965456846
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03995912965456846
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.03995912965456846
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03995912965456846
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03995912965456846
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.03995912965456846
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03995912965456846
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03995912965456846
TARP SYNDROME	0.001086973	0.03995912965456846
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03995912965456846
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.03995912965456846
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.03995912965456846
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.03995912965456846
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03995912965456846
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.03995912965456846
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.03995912965456846
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.03995912965456846
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.03995912965456846
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.03995912965456846
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.03995912965456846
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.03995912965456846
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03995912965456846
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.03995912965456846
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.03995912965456846
NETHERTON SYNDROME	0.001086973	0.03995912965456846
WYBURN-MASON SYNDROME	0.001086973	0.03995912965456846
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.03995912965456846
CRANIOPHARYNGIOMA	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.03995912965456846
DUANE RETRACTION SYNDROME	0.001086973	0.03995912965456846
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.03995912965456846
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.03995912965456846
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.03995912965456846
TIMOTHY SYNDROME; TS	0.001086973	0.03995912965456846
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.03995912965456846
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.03995912965456846
ALG1-CDG	0.001086973	0.03995912965456846
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.03995912965456846
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.03995912965456846
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.03995912965456846
CLASSIC PHENYLKETONURIA	0.001086973	0.03995912965456846
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.03995912965456846
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.03995912965456846
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.03995912965456846
MUENKE SYNDROME	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.03995912965456846
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.03995912965456846
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.03995912965456846
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03995912965456846
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03995912965456846
HOLOPROSENCEPHALY 7	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.03995912965456846
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03995912965456846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.03995912965456846
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.03995912965456846
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.03995912965456846
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.03995912965456846
MACDERMOT-WINTER SYNDROME	0.001086973	0.03995912965456846
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.03995912965456846
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03995912965456846
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03995912965456846
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.03995912965456846
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03995912965456846
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.03995912965456846
LANDAU-KLEFFNER SYNDROME	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03995912965456846
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.03995912965456846
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.03995912965456846
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.03995912965456846
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03995912965456846
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.03995912965456846
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.03995912965456846
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.03995912965456846
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.03995912965456846
MIRAGE SYNDROME; MIRAGE	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.03995912965456846
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03995912965456846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03995912965456846
LISSENCEPHALY 4	0.001086973	0.03995912965456846
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.03995912965456846
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.03995912965456846
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.03995912965456846
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03995912965456846
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03995912965456846
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03995912965456846
RECOMBINANT 8 SYNDROME	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03995912965456846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03995912965456846
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.03995912965456846
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001086973	0.03995912965456846
DONNAI-BARROW SYNDROME	0.001086973	0.03995912965456846
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.03995912965456846
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.03995912965456846
PALLISTER-HALL SYNDROME	0.001086973	0.03995912965456846
KBG SYNDROME	0.001086973	0.03995912965456846
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.03995912965456846
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03995912965456846
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.03995912965456846
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03995912965456846
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.03995912965456846
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.03995912965456846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.03995912965456846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.03995912965456846
15Q14 MICRODELETION SYNDROME	0.001086973	0.03995912965456846
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.03995912965456846
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03995912965456846
ISOVALERIC ACIDEMIA	0.001086973	0.03995912965456846
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03995912965456846
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.03995912965456846
OPTIC PATHWAY GLIOMA	0.001086973	0.03995912965456846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.03995912965456846
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03995912965456846
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.03995912965456846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.03995912965456846
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03995912965456846
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03995912965456846
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.03995912965456846
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03995912965456846
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.03995912965456846
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.03995912965456846
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03995912965456846
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03995912965456846
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.03995912965456846
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03995912965456846
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.03995912965456846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03995912965456846
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.03995912965456846
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.03995912965456846
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.03995912965456846
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.03995912965456846
MUCOPOLYSACCHARIDOSIS TYPE 2	0.001086973	0.03995912965456846
PHACE ASSOCIATION	0.001086973	0.03995912965456846
PFEIFFER SYNDROME TYPE 2	0.001086973	0.03995912965456846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.03995912965456846
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.03995912965456846
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03995912965456846
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.03995912965456846
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.03995912965456846
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.03995912965456846
HYDRANENCEPHALY	0.001086973	0.03995912965456846
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.03995912965456846
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.03995912965456846
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.03995912965456846
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.03995912965456846
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.03995912965456846
JOUBERT SYNDROME 26	0.000545554	0.02005556993556274
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02005556993556274
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.02005556993556274
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02005556993556274
SEPTOOPTIC DYSPLASIA	0.000545554	0.02005556993556274
MIETENS SYNDROME	0.000545554	0.02005556993556274
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02005556993556274
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02005556993556274
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.02005556993556274
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02005556993556274
TRANSALDOLASE DEFICIENCY	0.000545554	0.02005556993556274
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02005556993556274
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02005556993556274
BARDET-BIEDL SYNDROME 2	0.000545554	0.02005556993556274
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.02005556993556274
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.02005556993556274
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02005556993556274
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02005556993556274
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.02005556993556274
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02005556993556274
NOONAN SYNDROME 11; NS11	0.000545554	0.02005556993556274
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.02005556993556274
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.02005556993556274
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02005556993556274
RABSON-MENDENHALL SYNDROME	0.000545554	0.02005556993556274
RAHMAN SYNDROME	0.000545554	0.02005556993556274
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02005556993556274
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.02005556993556274
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.02005556993556274
WOLMAN DISEASE	0.000545554	0.02005556993556274
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.02005556993556274
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.02005556993556274
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.02005556993556274
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02005556993556274
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02005556993556274
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.02005556993556274
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02005556993556274
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.02005556993556274
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.02005556993556274
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.02005556993556274
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02005556993556274
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.02005556993556274
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.02005556993556274
ALAZAMI-YUAN SYNDROME	0.000545554	0.02005556993556274
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.02005556993556274
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02005556993556274
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02005556993556274
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.02005556993556274
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02005556993556274
CULLER-JONES SYNDROME; CJS	0.000545554	0.02005556993556274
SECKEL SYNDROME 9; SCKL9	0.000545554	0.02005556993556274
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02005556993556274
XIA-GIBBS SYNDROME	0.000545554	0.02005556993556274
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.02005556993556274
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.02005556993556274
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.02005556993556274
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.02005556993556274
CONGENITAL VARICELLA SYNDROME	0.000545554	0.02005556993556274
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02005556993556274
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.02005556993556274
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02005556993556274
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.02005556993556274
OKAMOTO SYNDROME	0.000545554	0.02005556993556274
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.02005556993556274
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02005556993556274
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.02005556993556274
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.02005556993556274
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.02005556993556274
NOONAN SYNDROME 2; NS2	0.000545554	0.02005556993556274
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.02005556993556274
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02005556993556274
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02005556993556274
MOSAIC TRISOMY 9	0.000545554	0.02005556993556274
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02005556993556274
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02005556993556274
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.02005556993556274
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02005556993556274
TRISOMY 9P	0.000545554	0.02005556993556274
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02005556993556274
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.02005556993556274
NOONAN SYNDROME 9; NS9	0.000545554	0.02005556993556274
AL-RAQAD SYNDROME; ARS	0.000545554	0.02005556993556274
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.02005556993556274
FRIAS SYNDROME	0.000545554	0.02005556993556274
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.02005556993556274
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.02005556993556274
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.02005556993556274
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.02005556993556274
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02005556993556274
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.02005556993556274
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02005556993556274
BRESEK SYNDROME	0.000545554	0.02005556993556274
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.02005556993556274
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.02005556993556274
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.02005556993556274
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02005556993556274
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02005556993556274
HURLER SYNDROME	0.000545554	0.02005556993556274
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.02005556993556274
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02005556993556274
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02005556993556274
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.02005556993556274
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02005556993556274
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02005556993556274
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02005556993556274
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.02005556993556274
EVEN-PLUS SYNDROME	0.000545554	0.02005556993556274
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02005556993556274
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.02005556993556274
SYNDROMIC DIARRHEA	0.000545554	0.02005556993556274
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.02005556993556274
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02005556993556274
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02005556993556274
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.02005556993556274
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02005556993556274
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02005556993556274
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.02005556993556274
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.02005556993556274
LIG4 SYNDROME	0.000545554	0.02005556993556274
CHOPS SYNDROME; CHOPS	0.000545554	0.02005556993556274
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.02005556993556274
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02005556993556274
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.02005556993556274
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02005556993556274
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02005556993556274
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.02005556993556274
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02005556993556274
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.02005556993556274
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.02005556993556274
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.02005556993556274
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.02005556993556274
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02005556993556274
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.02005556993556274
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02005556993556274
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02005556993556274
TREACHER-COLLINS SYNDROME	0.000545554	0.02005556993556274
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02005556993556274
MEIER-GORLIN SYNDROME 7	0.000545554	0.02005556993556274
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02005556993556274
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02005556993556274
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02005556993556274
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.02005556993556274
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02005556993556274
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.02005556993556274
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02005556993556274
HYDROXYKYNURENINURIA	0.000545554	0.02005556993556274
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02005556993556274
CDAGS SYNDROME	0.000545554	0.02005556993556274
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.02005556993556274
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.02005556993556274
AUSTRALIA ANTIGEN	0.000545554	0.02005556993556274
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.02005556993556274
CHAR SYNDROME	0.000545554	0.02005556993556274
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02005556993556274
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02005556993556274
OGDEN SYNDROME	0.000545554	0.02005556993556274
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.02005556993556274
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.02005556993556274
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02005556993556274
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.02005556993556274
ZEBRA BODY MYOPATHY	0.000545554	0.02005556993556274
RIGID SPINE SYNDROME	0.000545554	0.02005556993556274
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.02005556993556274
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.02005556993556274
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02005556993556274
FARBER DISEASE	0.000545554	0.02005556993556274
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.02005556993556274
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02005556993556274
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.02005556993556274
ROBERTS SYNDROME	0.000545554	0.02005556993556274
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02005556993556274
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02005556993556274
ABETAL34V AMYLOIDOSIS	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02005556993556274
CHAR SYNDROME	0.000545554	0.02005556993556274
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02005556993556274
SAY-BARBER-MILLER SYNDROME	0.000545554	0.02005556993556274
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02005556993556274
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02005556993556274
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02005556993556274
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02005556993556274
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02005556993556274
HOLOPROSENCEPHALY 11	0.000545554	0.02005556993556274
STEEL SYNDROME; STLS	0.000545554	0.02005556993556274
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.02005556993556274
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.02005556993556274
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02005556993556274
ZECHI-CEIDE SYNDROME	0.000545554	0.02005556993556274
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.02005556993556274
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.02005556993556274
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.02005556993556274
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.02005556993556274
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.02005556993556274
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.02005556993556274
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02005556993556274
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02005556993556274
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.02005556993556274
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.02005556993556274
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.02005556993556274
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.02005556993556274
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02005556993556274
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02005556993556274
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02005556993556274
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02005556993556274
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.02005556993556274
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.02005556993556274
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02005556993556274
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.02005556993556274
RING CHROMOSOME 12 SYNDROME	0.000545554	0.02005556993556274
JAWAD SYNDROME	0.000545554	0.02005556993556274
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.02005556993556274
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.02005556993556274
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.02005556993556274
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.02005556993556274
HYPERTRICHOSIS CUBITI	0.000545554	0.02005556993556274
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02005556993556274
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.02005556993556274
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02005556993556274
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02005556993556274
TEMTAMY SYNDROME	0.000545554	0.02005556993556274
SECKEL SYNDROME 8; SCKL8	0.000545554	0.02005556993556274
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02005556993556274
DYSKERATOSIS CONGENITA	0.000545554	0.02005556993556274
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02005556993556274
DEXTROCARDIA	0.000545554	0.02005556993556274
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02005556993556274
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.02005556993556274
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02005556993556274
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.02005556993556274
TRISOMY 8Q	0.000545554	0.02005556993556274
DISTAL TRISOMY 6P	0.000545554	0.02005556993556274
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.02005556993556274
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02005556993556274
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.02005556993556274
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02005556993556274
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.02005556993556274
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.02005556993556274
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02005556993556274
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.02005556993556274
TARP SYNDROME; TARPS	0.000545554	0.02005556993556274
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.02005556993556274
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.02005556993556274
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02005556993556274
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02005556993556274
OROTIC ACIDURIA	0.000545554	0.02005556993556274
ALAZAMI SYNDROME; ALAZS	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02005556993556274
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.02005556993556274
RAINE SYNDROME	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.02005556993556274
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02005556993556274
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.02005556993556274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.02005556993556274
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.02005556993556274
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.02005556993556274
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02005556993556274
CINCA SYNDROME	0.000545554	0.02005556993556274
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.02005556993556274
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02005556993556274
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.02005556993556274
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.02005556993556274
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.02005556993556274
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02005556993556274
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.02005556993556274
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.02005556993556274
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.02005556993556274
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02005556993556274
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02005556993556274
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.02005556993556274
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02005556993556274
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.02005556993556274
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.02005556993556274
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.02005556993556274
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02005556993556274
EPIDERMAL NEVUS SYNDROME	0.000545554	0.02005556993556274
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02005556993556274
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.02005556993556274
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02005556993556274
ISOLATED PLAGIOCEPHALY	0.000545554	0.02005556993556274
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.02005556993556274
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02005556993556274
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.02005556993556274
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02005556993556274
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02005556993556274
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02005556993556274
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02005556993556274
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02005556993556274
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02005556993556274
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.02005556993556274
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02005556993556274
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02005556993556274
ATELOSTEOGENESIS TYPE III	0.000545554	0.02005556993556274
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.02005556993556274
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.02005556993556274
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.02005556993556274
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02005556993556274
LOWRY-MACLEAN SYNDROME	0.000545554	0.02005556993556274
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02005556993556274
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.019903559719005717
SUBEPENDYMOMA	0.000541419	0.019903559719005717
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.019903559719005717
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.019903559719005717
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.019903559719005717
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.019903559719005717
EPENDYMOMA	0.000541419	0.019903559719005717
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.019903559719005717
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.019903559719005717
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.019903559719005717
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.019903559719005717
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.019903559719005717
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.019903559719005717
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.019903559719005717
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.019903559719005717
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.019903559719005717
EBOLA HEMORRHAGIC FEVER	0.000541419	0.019903559719005717
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.019903559719005717
WORSTER-DROUGHT SYNDROME	0.000541419	0.019903559719005717
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.019903559719005717
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.019903559719005717
PARTINGTON SYNDROME	0.000541419	0.019903559719005717
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.019903559719005717
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.019903559719005717
RIFT VALLEY FEVER	0.000541419	0.019903559719005717
THREONINEMIA	0.000541419	0.019903559719005717
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.019903559719005717
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.019903559719005717
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.019903559719005717
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.019903559719005717
DERMOTRICHIC SYNDROME	0.000541419	0.019903559719005717
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.019903559719005717
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.019903559719005717
IMMUNODEFICIENCY 47	0.000541419	0.019903559719005717
PSEUDO-TORCH SYNDROME 2	0.000541419	0.019903559719005717
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.019903559719005717
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.019903559719005717
FILIPPI SYNDROME; FLPIS	0.000541419	0.019903559719005717
PARIETAL FORAMINA	0.000541419	0.019903559719005717
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.019903559719005717
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.019903559719005717
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.019903559719005717
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.019903559719005717
CONGENITAL HYDROCEPHALUS	0.000541419	0.019903559719005717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.019903559719005717
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.019903559719005717
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.019903559719005717
INCONTINENTIA PIGMENTI; IP	0.000541419	0.019903559719005717
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.019903559719005717
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.019903559719005717
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.019903559719005717
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.019903559719005717
ASPARTYLGLUCOSAMINURIA	0.000541419	0.019903559719005717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.019903559719005717
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.019903559719005717
TAY-SACHS DISEASE; TSD	0.000541419	0.019903559719005717
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.019903559719005717
CENTRAL DIABETES INSIPIDUS	0.000541419	0.019903559719005717
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.019903559719005717
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.019903559719005717
STURGE-WEBER SYNDROME	0.000541419	0.019903559719005717
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.019903559719005717
NIPAH VIRUS DISEASE	0.000541419	0.019903559719005717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.019903559719005717
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.019903559719005717
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.019903559719005717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.019903559719005717
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.019903559719005717
PFEIFFER SYNDROME TYPE 3	0.000541419	0.019903559719005717
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.019903559719005717
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.019903559719005717
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.019903559719005717
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.019903559719005717
DARIER-WHITE DISEASE; DAR	0.000541419	0.019903559719005717
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.019903559719005717
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.019903559719005717
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.019903559719005717
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.019903559719005717
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.019903559719005717
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.019903559719005717
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.019903559719005717
CROUZON SYNDROME	0.000541419	0.019903559719005717
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.019903559719005717
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.019903559719005717
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.019903559719005717
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.019903559719005717
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.019903559719005717
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.019903559719005717
MERCURY POISONING	0.000541419	0.019903559719005717
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.019903559719005717
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.019903559719005717
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.019903559719005717
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.019903559719005717
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.019903559719005717
MOYNAHAN SYNDROME	0.000541419	0.019903559719005717
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.019903559719005717
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.019903559719005717
GLIOBLASTOMA	0.000541419	0.019903559719005717
TAKAYASU ARTERITIS	0.000541419	0.019903559719005717
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.019903559719005717
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.019903559719005717
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.019903559719005717
ADAMS-OLIVER SYNDROME	0.000541419	0.019903559719005717
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.019903559719005717
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.019903559719005717
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.019903559719005717
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.019903559719005717
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.019903559719005717
ALZHEIMER DISEASE 3; AD	0.000541419	0.019903559719005717
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.019903559719005717
INSULINOMA	0.000541419	0.019903559719005717
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.019903559719005717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.019903559719005717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.019903559719005717
HYPERPROLINEMIA TYPE 1	0.000541419	0.019903559719005717
PAPILLORENAL SYNDROME	0.000541419	0.019903559719005717
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.019903559719005717
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.019903559719005717
GALACTOSIALIDOSIS	0.000541419	0.019903559719005717
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.019903559719005717
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.019903559719005717
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.019903559719005717
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.019903559719005717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.019903559719005717
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.019903559719005717
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.019903559719005717
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.019903559719005717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.019903559719005717
MOYAMOYA DISEASE	0.000541419	0.019903559719005717
EPILEPSY, READING	0.000541419	0.019903559719005717
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.019903559719005717
PINEOBLASTOMA	0.000541419	0.019903559719005717
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.019903559719005717
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.019903559719005717
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.019903559719005717
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.019903559719005717
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.019903559719005717
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.019903559719005717
PERRAULT SYNDROME 3	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.019903559719005717
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.019903559719005717
CYSTATHIONINURIA	0.000541419	0.019903559719005717
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.019903559719005717
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.019903559719005717
MICROSPORIDIOSIS	0.000541419	0.019903559719005717
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.019903559719005717
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.019903559719005717
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.019903559719005717
FRONTAL ENCEPHALOCELE	0.000541419	0.019903559719005717
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.019903559719005717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.019903559719005717
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.019903559719005717
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.019903559719005717
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.019903559719005717
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.019903559719005717
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.019903559719005717
KLEEFSTRA SYNDROME	0.000541419	0.019903559719005717
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.019903559719005717
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.019903559719005717
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.019903559719005717
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.019903559719005717
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.019903559719005717
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.019903559719005717
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.019903559719005717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.019903559719005717
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.019903559719005717
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.019903559719005717
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.019903559719005717
PROTEUS SYNDROME	0.000541419	0.019903559719005717
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.019903559719005717
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.019903559719005717
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.019903559719005717
RABIES	0.000541419	0.019903559719005717
CADASIL	0.000541419	0.019903559719005717
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.019903559719005717
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.019903559719005717
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.019903559719005717
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.019903559719005717
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.019903559719005717
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.019903559719005717
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.019903559719005717
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.019903559719005717
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.019903559719005717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.019903559719005717
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.019903559719005717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.019903559719005717
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.019903559719005717
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.019903559719005717
ATYPICAL RETT SYNDROME	0.000541419	0.019903559719005717
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.019903559719005717
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.019903559719005717
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.019903559719005717
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.019903559719005717
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.019903559719005717
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.019903559719005717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.019903559719005717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.019903559719005717
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.019903559719005717
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.019903559719005717
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.019903559719005717
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.019903559719005717
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.019903559719005717
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.019903559719005717
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.019903559719005717
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.019903559719005717
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.019903559719005717
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.019903559719005717
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.019903559719005717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.019903559719005717
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.019903559719005717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.019903559719005717
KIFAFA SEIZURE DISORDER	0.000541419	0.019903559719005717
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.019903559719005717
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.019903559719005717
SECKEL SYNDROME 1; SCKL1	0.000541419	0.019903559719005717
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.019903559719005717
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.019903559719005717
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.019903559719005717
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.019903559719005717
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.019903559719005717
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.019903559719005717
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.019903559719005717
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.019903559719005717
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.019903559719005717
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.019903559719005717
PROLACTINOMA	0.000541419	0.019903559719005717
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.019903559719005717
FOUNTAIN SYNDROME	0.000541419	0.019903559719005717
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.019903559719005717
SANJAD-SAKATI SYNDROME	0.000541419	0.019903559719005717
BETA-MANNOSIDOSIS	0.000541419	0.019903559719005717
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.019903559719005717
GURRIERI SYNDROME	0.000541419	0.019903559719005717
BERNARD-SOULIER SYNDROME	0.000541419	0.019903559719005717
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.019903559719005717
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.019903559719005717
PORENCEPHALY	0.000541419	0.019903559719005717
FRYNS SYNDROME; FRNS	0.000541419	0.019903559719005717
MYASTHENIA GRAVIS	0.000541419	0.019903559719005717
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.019903559719005717
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.019903559719005717
LIPOID PROTEINOSIS	0.000541419	0.019903559719005717
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.019903559719005717
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.019903559719005717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.019903559719005717
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.019903559719005717
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.019903559719005717
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.019903559719005717
ISOLATED BILIARY ATRESIA	0.000541419	0.019903559719005717
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.019903559719005717
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.019903559719005717
RAMON SYNDROME	0.000541419	0.019903559719005717
HYPERPROLINEMIA, TYPE II	0.000541419	0.019903559719005717
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.019903559719005717
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.019903559719005717
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.019903559719005717
NEVUS COMEDONICUS SYNDROME	0.000541419	0.019903559719005717
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.019903559719005717
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.019903559719005717
HYPER-BETA-ALANINEMIA	0.000541419	0.019903559719005717
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.019903559719005717
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.019903559719005717
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.019903559719005717
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.019903559719005717
DYSOSTEOSCLEROSIS	0.000541419	0.019903559719005717
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.019903559719005717
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.019903559719005717
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.019903559719005717
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.019903559719005717
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.019903559719005717
LUJO HEMORRHAGIC FEVER	0.000541419	0.019903559719005717
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.019903559719005717
AICA-RIBOSIDURIA	0.000541419	0.019903559719005717
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.019903559719005717
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.019903559719005717
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.019903559719005717
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.019903559719005717
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.019903559719005717
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.019903559719005717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.019903559719005717
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.019903559719005717
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.019903559719005717
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.019903559719005717
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.019903559719005717
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.019903559719005717
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.019903559719005717
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.019903559719005717
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.019903559719005717
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.019903559719005717
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.019903559719005717
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.019903559719005717
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.019903559719005717
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.019903559719005717
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.019903559719005717
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.019903559719005717
PHENYLKETONURIA	0.000541419	0.019903559719005717
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.019903559719005717
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.019903559719005717
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.019903559719005717
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.019903559719005717
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.019903559719005717
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.019903559719005717
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.019903559719005717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.019903559719005717
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.019903559719005717
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.019903559719005717
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.019903559719005717
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.019903559719005717
SNEDDON SYNDROME	0.000541419	0.019903559719005717
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.019903559719005717
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.019903559719005717
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.019903559719005717
STURGE-WEBER SYNDROME	0.000541419	0.019903559719005717
RAMON SYNDROME	0.000541419	0.019903559719005717
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.019903559719005717
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.019903559719005717
CRANIOSYNOSTOSIS 2	0.000541419	0.019903559719005717
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.019903559719005717
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.019903559719005717
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.019903559719005717
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.019903559719005717
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.019903559719005717
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.019903559719005717
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.019903559719005717
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.019903559719005717
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.019903559719005717
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.019903559719005717
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.019903559719005717
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.019903559719005717
CRYPTOCOCCOSIS	0.000541419	0.019903559719005717
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.019903559719005717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.019903559719005717
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.019903559719005717
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.019903559719005717
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.019903559719005717
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.019903559719005717
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.019903559719005717
NOCARDIOSIS	0.000541419	0.019903559719005717
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.019903559719005717
MOGS-CDG	0.000541419	0.019903559719005717
20P13 MICRODELETION SYNDROME	0.000541419	0.019903559719005717
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.019903559719005717
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.019903559719005717
ALG2-CDG	0.000541419	0.019903559719005717
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.019903559719005717
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.019903559719005717
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.019903559719005717
AUTISM	0.000541419	0.019903559719005717
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.019903559719005717
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.019903559719005717
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.019903559719005717
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.019903559719005717
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.019903559719005717
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.019903559719005717
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.019903559719005717
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.019903559719005717
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.019903559719005717
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.019903559719005717
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.019903559719005717
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.019903559719005717
ROSAÏ-DORFMAN DISEASE	0.000541419	0.019903559719005717
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.019903559719005717
NASU-HAKOLA DISEASE	0.000541419	0.019903559719005717
ENCEPHALITIS LETHARGICA	0.000541419	0.019903559719005717
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.019903559719005717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.019903559719005717
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.019903559719005717
SCRUB TYPHUS	0.000541419	0.019903559719005717
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.019903559719005717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.019903559719005717
COWDEN SYNDROME 5; CWS5	0.000541419	0.019903559719005717
SNEDDON SYNDROME	0.000541419	0.019903559719005717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.019903559719005717
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.019903559719005717
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.019903559719005717
COWDEN SYNDROME 6; CWS6	0.000541419	0.019903559719005717
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.019903559719005717
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.019903559719005717
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.019903559719005717
47,XYY SYNDROME	0.000541419	0.019903559719005717
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.019903559719005717
